10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 29, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-35370

Luxfer Holdings PLC

(Exact Name of Registrant as Specified in Its Charter)

England and Wales	98-1024030
State or Other Jurisdiction of  Incorporation or Organization	I.R.S. Employer Identification No.

Lumns Lane, Manchester, M27 8LN

Address of principal executive offices

Registrant’s telephone number, including area code: +1 414-269-2419

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Ordinary Shares, nominal value £0.50 each	LXFR	New York Stock Exchange

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    x No    o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes    x No    o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See definition of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.:

Large accelerated filer	o	Accelerated Filer	x
Non-accelerated filer	o	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes    ☐ No    x

The number of shares outstanding of Registrant’s only class of ordinary stock on March 29, 2020, was 27,500,415.

TABLE OF CONTENTS

		Page
PART I FINANCIAL INFORMATION
Item 1.	Condensed Financial Statements (unaudited)	1
	Condensed Consolidated Statements of Income (unaudited)	1
	Condensed Consolidated Statements of Comprehensive (Loss) / Income (unaudited)	2
	Condensed Consolidated Balance Sheets (unaudited)	3
	Condensed Consolidated Statements of Cash Flows (unaudited)	4
	Condensed Consolidated Statements of Changes in Equity (unaudited)	5
	Notes to Condensed Consolidated Financial Statements (unaudited)	6
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	19
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.	Controls and Procedures	30
PART II OTHER INFORMATION
Item 1.	Legal Proceedings	31
Item 1A.	Risk Factors	31
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
Item 6.	Exhibits	32
	Signatures	33

PART I - FINANCIAL INFORMATION

Item 1.        Condensed Financial Statements (unaudited)

LUXFER HOLDINGS PLC

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

	First Quarter
In millions, except share and per-share data	2020			2019
Net sales	$	103.8		$	120.4
Cost of goods sold	(79.3		)	(90.3		)
Gross profit	24.5			30.1
Selling, general and administrative expenses	(12.8		)	(16.4		)
Research and development	(0.7		)	(1.4		)
Restructuring charges	(2.8		)	(9.0		)
Impairment charges	—			0.2
Acquisition related costs	(0.2		)	(4.6		)
Operating income / (loss)	8.0			(1.1		)
Interest expense	(1.2		)	(1.1		)
Defined benefit pension credit	1.1			0.6
Income / (loss) before income taxes and equity in net income of affiliates	7.9			(1.6		)
Provision for income taxes	(1.7		)	(2.1		)
Income / (loss) before equity in net income of affiliates	6.2			(3.7		)
Equity income / (loss) of affiliates (net of tax)	—			(0.1		)
Net income / (loss)	$	6.2		$	(3.8	)
Earnings / (loss) per share
Basic	$	0.23		$	(0.14	)
Diluted	$	0.22		$	(0.14	)
Weighted average ordinary shares outstanding
Basic	27,440,423			27,032,677
Diluted	27,894,058			27,032,677

See accompanying notes to condensed consolidated financial statements

1

LUXFER HOLDINGS PLC

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) / INCOME (UNAUDITED)

	First Quarter
In millions	2020			2019
Net income / (loss)	$	6.2		$	(3.8	)
Other comprehensive (loss) / income
Net change in foreign currency translation adjustment	(7.6		)	1.4
Pension and post-retirement actuarial gains , net of $0.1 and $0.1 tax, respectively	0.3			0.5
Cash flow hedges, net of $0.0 and $0.0 of tax, respectively	—			0.2
Other comprehensive (loss) / income, net of tax	(7.3		)	2.1
Total comprehensive loss	$	(1.1	)	$	(1.7	)

See accompanying notes to condensed consolidated financial statements

2

LUXFER HOLDINGS PLC

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

	March 29,			December 31,
In millions, except share and per-share data	2020			2019
Current assets
Cash and cash equivalents	$	17.3		$	10.2
Restricted cash	0.1			0.1
Accounts and other receivables, net of allowances of $1.9 and $1.3, respectively	73.6			66.3
Inventories	93.9			94.5
Other current assets	4.1			5.0
Total current assets	$	189.0		$	176.1
Non-current assets
Property, plant and equipment, net	$	94.3		$	98.9
Right-of-use assets from operating leases	13.5			14.8
Goodwill	66.2			68.8
Intangibles, net	13.0			13.6
Deferred tax assets	14.4			15.8
Investments and loans to joint ventures and other affiliates	2.1			2.3
Total assets	$	392.5		$	390.3
Current liabilities
Accounts payable	$	31.6		$	36.4
Accrued liabilities	24.8			25.2
Taxes on income	0.6			0.1
Other current liabilities	12.2			12.3
Total current liabilities	$	69.2		$	74.0
Non-current liabilities
Long-term debt	$	108.8		$	91.4
Pensions and other retirement benefits	30.4			35.2
Deferred tax liabilities	2.6			2.5
Other non-current liabilities	11.7			12.8
Total liabilities	$	222.7		$	215.9
Shareholders' equity
Ordinary shares of £0.50 par value; authorized 40,000,000 shares for 2020 and 2019; issued and outstanding 29,000,000 shares for 2020 and 2019	$	26.6		$	26.6
Deferred shares of £0.0001 par value; authorized issued and outstanding 761,835,338,444 shares for 2020 and 2019	149.9			149.9
Additional paid-in capital	68.2			68.4
Treasury shares	(4.0		)	(4.0		)
Own shares held by ESOP	(1.6		)	(1.7		)
Retained earnings	87.6			84.8
Accumulated other comprehensive loss	(156.9		)	(149.6		)
Total shareholders' equity	$	169.8		$	174.4
Total liabilities and shareholders' equity	$	392.5		$	390.3

See accompanying notes to condensed consolidated financial statements

3

LUXFER HOLDINGS PLC

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

	First Quarter
In millions	2020			2019
Operating activities
Net income / (loss)	$	6.2		$	(3.8	)
Adjustments to reconcile net income / (loss) to net cash used for operating activities
Equity income / (loss) of affiliates	—			0.1
Depreciation	3.4			3.4
Amortization of purchased intangible assets	0.2			0.3
Amortization of debt issuance costs	0.1			0.1
Share-based compensation charges	0.5			2.6
Deferred income taxes	0.2			0.8
Asset impairment charges	—			(0.2		)
Defined benefit pension credit	(1.1		)	(0.6		)
Defined benefit pension contributions	(1.4		)	(1.9		)
Changes in assets and liabilities
Accounts and other receivables	(5.6		)	(10.4		)
Inventories	(2.1		)	(3.6		)
Other current assets	0.7			—
Accounts payable	(7.3		)	(0.8		)
Accrued liabilities	0.8			(1.7		)
Other current liabilities	1.1			7.2
Other non-current assets and liabilities	(0.2		)	0.7
Net cash used for operating activities	$	(4.5	)	$	(7.8	)
Investing activities
Capital expenditures	$	(2.5	)	$	(3.2	)
Net cash used for investing activities	$	(2.5	)	$	(3.2	)
Financing activities
Net drawdown of short-term borrowings	$	—		$	4.2
Net drawdown of long-term borrowings	18.9			11.3
Deferred consideration paid	(0.4		)	(0.5		)
Proceeds from sale of shares	0.1			1.4
Share-based compensation cash paid	(0.7		)	(1.8		)
Dividends paid	(3.4		)	(3.4		)
Net cash from financing activities	$	14.5		$	11.2
Effect of exchange rate changes on cash and cash equivalents	(0.4		)	0.2
Net increase	$	7.1		$	0.4
Cash, cash equivalents and restricted cash; beginning of year	10.3			14.1
Cash, cash equivalents and restricted cash; end of the First Quarter	17.4			14.5
Supplemental cash flow information:
Interest payments	$	1.3		$	1.1
Income tax payments	0.1			—

See accompanying notes to condensed consolidated financial statements

4

LUXFER HOLDINGS PLC

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)

In millions,	Ordinary share capital		Deferred share capital		Additional paid-in capital			Treasury shares Number		Treasury shares Amount			Own shares held by ESOP Number		Own shares held by ESOP Amount			Retained earnings			Accumulated other comprehensive loss			Total equity
At January 1, 2019	$	26.6	$	149.9	$	65.6		(0.4	)	$	(4.3	)	(1.6	)	$	(2.2	)	$	95.3		$	(146.6	)	$	184.3
Net loss	—		—		—			—		—			—		—			(3.8		)	—			(3.8		)
Shares sold from ESOP	—		—		1.3			—		—			0.1		0.1			—			—			1.4
Other comprehensive income, net of tax	—		—		—			—		—			—		—			—			2.1			2.1
Dividends declared	—		—		—			—		—			—		—			(3.4		)	—			(3.4		)
Share-based compensation	—		—		(0.8		)	—		—			—		—			—			—			(0.8		)
Utilization of treasury shares to satisfy share based compensation	—		—		(0.2		)	—		—			0.1		0.2			—			—			—
At March 31, 2019	$	26.6	$	149.9	$	65.9		(0.5	)	$	(4.3	)	(1.4	)	$	(1.9	)	$	88.1		$	(144.5	)	$	179.8
At January 1, 2020	$	26.6	$	149.9	$	68.4		(0.4	)	$	(4.0	)	(1.2	)	$	(1.7	)	$	84.8		$	(149.6	)	$	174.4
Net income	—		—		—			—		—			—		—			6.2			—			6.2
Other comprehensive loss, net of tax	—		—		—			—		—			—		—			—			(7.3		)	(7.3		)
Dividends declared	—		—		—			—		—			—		—			(3.4		)	—			(3.4		)
Share-based compensation	—		—		0.5			—		—			—		—			—			—			0.5
Utilization of shares from ESOP to satisfy share based compensation	—		—		(0.7		)	—		—			0.1		0.1			—			—			(0.6		)
At March 29, 2020	$	26.6	$	149.9	$	68.2		(0.4	)	$	(4.0	)	(1.1	)	$	(1.6	)	$	87.6		$	(156.9	)	$	169.8

Ordinary share capital includes 29,000,000 shares in 2020, 29,000,000 shares in 2019, respectively.

Deferred share capital includes 761,835,338,444 shares in 2020, and 761,835,338,444 shares in 2019.

See accompanying notes to condensed consolidated financial statements

5

LUXFER HOLDINGS PLC

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.    Basis of Presentation and Responsibility for interim Financial Statements

We prepared the accompanying unaudited consolidated condensed financial statements of Luxfer Holdings PLC and all wholly-owned, majority owned or otherwise controlled subsidiaries on the same basis as our annual audited financial statements, except for the adoption for Accounting Standards Update ("ASU") 2016-13, "current expected credit loss model". We condensed or omitted certain information and footnote disclosures normally included in our annual audited financial statements, which we prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP).

Our quarterly financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2019. As used in this report, the terms "we," "us," "our," "Luxfer" and "the Company" mean Luxfer Holdings PLC and its subsidiaries, unless the context indicates another meaning.

In the opinion of management, our financial statements reflect all adjustments, which are of a normal recurring nature, necessary for presentation of financial statements for interim periods in accordance with U.S. GAAP and with the instructions to Form 10-Q in Article 10 of Securities and Exchange Commission (SEC) Regulation S-X.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of our financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and any such differences may be material to our financial statements.

Our fiscal year ends on December 31. We report our interim quarterly periods on a 13-week quarter basis, ending on a Sunday. The First Quarter, 2020, ended March 29, 2020, and the First Quarter, 2019, ended March 31, 2019.

Impact of COVID-19 on the Financial Statements

In March 2020, the World Health Organization characterized the coronavirus ("COVID-19") a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the pandemic and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment, unprecedented market volatility and heightened degree of uncertainty resulting from COVID-19, we are currently unable to fully determine its future impact on our business. However, we are monitoring the progression of the pandemic and its potential effect on our financial position, results of operations and cash flows.

The Company recognizes that the COVID-19 pandemic constitutes a triggering event in accordance with ASC 350 Intangibles - Goodwill and Other, and has therefore performed an impairment assessment of its goodwill and other intangible assets. Based on current forecast information we did not identify any impairments, nor marginal outcomes. Assumptions and judgments are required in calculating the fair value of the reporting units. In developing our discounted cash flow analysis, assumptions about future revenues and expenses, capital expenditures and changes in working capital are based on our annual operating plan and long-term business plan for each of our reporting units. These plans take into consideration numerous factors including historical experience, anticipated future economic conditions, changes in raw material prices and growth expectations for the industries and end markets we participate in. These assumptions and judgments may change as we learn more about the impact of the COVID-19 pandemic

In relation to liquidity, the Company has access to a large revolving credit facility and has performed stress testing on financial covenants using current forecast information and has not identified any liquidity concerns.

Adoption of new accounting standards

Current expected credit loss ("CECL") model

On January 1, 2020, the Company adopted ASU 2016-13, financial instruments - Credit Losses (Topic 326): Measurement of credit losses on Financial Instruments prospectively. The ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including trade receivables.

• Under the CECL model, the Company is required to consider whether expected credit losses should be recognized for trade receivables that are considered “current” (i.e., not past due).

6

• When using historical loss rates in a provision matrix, the Company is required to consider whether and, if so, how the historical loss rates differ from what is currently expected over the life of the trade receivables (on the basis of current conditions and reasonable and supportable forecasts about the future).

Upon adoption, there was no adjustment made to opening retained earnings as at January 1, 2020.

As a result of implementing ASU 2016-13, the Company did not recognize any material additional allowance within Accounts and Other Receivables as at January 1, 2020. Accounts and Other Receivables are shown net of a $1.9 million allowance at March 29, 2020.

The Company is exposed to credit losses primarily through sales of products. The Company’s expected loss allowance methodology for accounts receivable is developed using historical collection experience, current and future economic and market conditions and a review of the current status of customers' trade accounts receivables. Due to the short-term nature of such receivables, the estimate of accounts receivable amounts that may not be collected is based on aging of the accounts receivable balances and the financial condition of customers. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. The Company considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic and determined that the estimate of credit losses was not significantly impacted.

Estimates are used to determine the allowance. It is based on assessment of anticipated receipts and all other historical, current and future information that is reasonably available.

The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected.

In millions	2020
Balance at January 1,	$	1.3
Adoption of ASU 2016-13, cumulative-effect adjustment to retained earnings	—
Provisions for expected credit losses	0.7
Other, including foreign currency translation	(0.1		)
Balance at March 29,	$	1.9

Accounting standards issued but not yet effective

None that will be material to the Company.

2.    Earnings per share

Basic earnings per share are computed by dividing net income for the period by the weighted-average number of ordinary shares outstanding, net of Treasury shares and shares held in ESOP. Diluted earnings per share are computed by dividing net income for the period by the weighted average number of ordinary shares outstanding and the dilutive ordinary shares equivalents.

Basic and diluted earnings per share were calculated as follows:

	First Quarter
In millions except share and per-share data	2020		2019
Basic earnings:
Net income / (loss)	$	6.2	$	(3.8	)
Weighted average number of £0.50 ordinary shares:
For basic earnings per share	27,440,423		27,032,677
Dilutive effect of potential common stock	453,635		—
For diluted earnings per share	27,894,058		27,032,677
Earnings / (loss) per share using weighted average number of ordinary shares outstanding:
Basic earnings / (loss) per ordinary share	$	0.23	$	(0.14	)
Diluted earnings / (loss) per ordinary share	$	0.22	$	(0.14	)

In the first quarter of 2019, basic average shares outstanding and diluted average shares outstanding were the same because the effect of potential shares of common stock was anti-dilutive since the Company generated a

7

net loss. As a result, 735,730 shares combined were not included in the computation of diluted EPS for the first quarter of 2019.

3.    Revenue

Disaggregated sales disclosures for the quarter ended March 29, 2020, and March 31, 2019, are included below and in Note 14, Segmental Information.

	First Quarter
	2020						2019
In millions	Gas Cylinders		Elektron		Total		Gas Cylinders		Elektron		Total
General industrial	$	11.9	$	27.7	$	39.6	$	13.1	$	30.6	$	43.7
Transportation	18.9		11.2		30.1		20.9		19.1		40.0
Defense and emergency	18.1		11.4		29.5		18.7		10.5		29.2
Healthcare	3.7		0.9		4.6		5.7		1.8		7.5
	$	52.6	$	51.2	$	103.8	$	58.4	$	62.0	$	120.4

The Company’s performance obligations are satisfied over time as work progresses or at a point in time. Design and tooling arrangements are the only contracts for which sales are recognized over time. Sales from these sources combined accounted for less than 1% of the Company’s sales for the quarters ended March 29, 2020, and March 31, 2019. All consideration from contracts with customers is included in these amounts.

The following table provides information about contract receivables, contract assets and contract liabilities from contracts with customers:

In millions	March 29, 2020			December 31, 2019
Contract receivables	$	1.5		$	1.7
Contract assets	0.5			1.3
Contract liabilities	(0.4		)	(0.5		)

Contract assets consist of $0.5 million accrued unbilled amounts relating to tooling revenue and are recognized in prepayments and accrued income in the consolidated balance sheets. Of the $1.3 million contract assets recognized as of December 31, 2019, $0.4 million was billed to customers and transferred to receivables as of March 29, 2020.

Contract liabilities of $0.4 million consist of advance payments and billing above costs incurred and are recognized as other current liabilities. Significant changes in contract liabilities balances during the period are as follows:

In millions	2020
As at January 1,	$	(0.5	)
Net (payments received) / amounts billed	(0.1		)
Net (costs incurred) / revenue recognized	0.2
As at March 29,	$	(0.4	)

8

4.    Restructuring

During the First Quarter of 2020 we continued execution of certain business restructuring initiatives aimed at reducing our fixed cost structure and realigning our business.The $2.8 million restructuring charge in 2020 was predominantly ($2.6 million) the result of further costs associated with the announced closure of Luxfer Gas Cylinders France, including one-time employee benefits, and associated legal and professional fees.

Restructuring-related costs included within Restructuring charges in the Condensed Consolidated Financial Statements by reportable segment were as follows:

	First Quarter
In millions	2020		2019
Severance and related costs
Gas Cylinders segment	$	2.6	$	8.9
Elektron segment	—		0.1
Other	0.2		—
Total restructuring charges	$	2.8	$	9.0

Activity related to restructuring, recorded in Other current liabilities in the consolidated balance sheets is summarized as follows:

In millions	2020
Balance at January 1,	$	6.5
Costs incurred	2.8
Cash payments and other	(2.4		)
Balance at March 29,	$	6.9

5.    Acquisition related costs

Acquisition-related costs of $0.2 million in 2020 represents amounts incurred in relation to M&A exploration activities net of a $0.1 million release of deferred contingent consideration.

Acquisition-related costs of $4.6 million in the First Quarter, 2019 related to a $3.5 million termination payment and our professional and legal fees incurred in connection with the aborted acquisition of Neo Performance Materials.

9

6.    Supplementary balance sheet information

	March 29,			December 31,
In millions	2020			2019
Accounts and other receivables
Trade receivables	$	62.2		$	52.4
Related parties	2.6			2.7
Prepayments and accrued income	4.9			6.7
Derivative financial instruments	0.4			0.3
Other receivables	3.5			4.2
Total accounts and other receivables	$	73.6		$	66.3
Inventories
Raw materials and supplies	$	34.0		$	33.4
Work-in-process	33.7			32.2
Finished goods	26.2			28.9
Total inventories	$	93.9		$	94.5
Other current assets
Held-for-sale assets	$	3.8		$	3.9
Income tax receivable	0.3			1.1
Total other current assets	$	4.1		$	5.0
Property, plant and equipment, net
Land, buildings and leasehold improvements	$	68.4		$	68.1
Machinery and equipment	278.2			287.7
Construction in progress	7.0			8.9
Total property, plant and equipment	353.6			364.7
Accumulated depreciation and impairment	(259.3		)	(265.8		)
Total property, plant and equipment, net	$	94.3		$	98.9
Other current liabilities
Contingent liabilities	$	7.0		$	6.6
Derivative financial instruments	0.6			—
Operating lease liability	3.1			3.3
Other current liabilities	1.5			2.4
Total other current liabilities	$	12.2		$	12.3
Other non-current liabilities
Contingent liabilities	$	0.9		$	0.9
Operating lease liability	10.6			11.7
Other non-current liabilities	0.2			0.2
Total other non-current liabilities	$	11.7		$	12.8

10

6.    Supplementary balance sheet information (continued)

Held-for-sale assets and liabilities

Held-for-sale assets	March 29,		December 31,
In millions	2020		2019
Property, plant and equipment	$	3.7	$	3.7
Inventory	0.1		0.2
Held-for-sale assets	$	3.8	$	3.9

During 2018, a building within our Elektron Segment was classified as held-for-sale assets, presented within other current assets. The building was part of a site closure announced in 2017 and were readily available for sale at December 31, 2018. The site at Riverhead, NY is now expected to be sold during 2020 and is included within held-for-sale assets as at March 29, 2020 and December 31, 2019.

7.     Goodwill and other identifiable intangible assets

Changes in goodwill during the First Quarter, ended March 29, 2020, were as follows:

In millions	Gas Cylinders			Elektron			Total
At January 1, 2020	$	27.0		$	41.8		$	68.8
Exchange difference	(1.6		)	(1.0		)	(2.6		)
Balance at March 29, 2020	$	25.4		$	40.8		$	66.2

Identifiable intangible assets consisted of the following:

	March 29, 2020							December 31, 2019
In millions	Gross		Accumulated amortization			Net		Gross		Accumulated amortization			Net
Customer relationships	$	13.4	$	(4.8	)	$	8.6	$	13.4	$	(4.6	)	$	8.8
Technology and trading related	7.6		(3.2		)	4.4		8.1		(3.3		)	4.8
	$	21.0	$	(8.0	)	$	13.0	$	21.5	$	(7.9	)	$	13.6

Identifiable intangible asset amortization expense was $0.2 million and $0.3 million for the First Quarter of 2020 and 2019 respectively.

Intangible asset amortization expense during the remainder of 2020 and over the next five years is expected to be approximately $0.5 million in 2020, $0.7 million in 2021, $0.7 million in 2022, $0.7 million in 2023, $0.7 million in 2024 and $0.7 million in 2025.

11

8.    Debt

Debt outstanding was as follows:

In millions	March 29, 2020			December 31, 2019
3.67% Loan Notes due 2021	$	25.0		$	25.0
4.88% Loan Notes due 2023	25.0			25.0
4.94% Loan Notes due 2026	25.0			25.0
Revolving credit facility	34.7			17.5
Unamortized debt issuance costs	(0.9		)	(1.1		)
Total debt	$	108.8		$	91.4
Less current portion	$	—		$	—
Non-current debt	$	108.8		$	91.4

The weighted-average interest rate on the revolving credit facility was 2.32% for the First Quarter of 2020 and 2.47% for the full-year 2019.

The maturity profile of the Company's debt, excluding unamortized issuance costs and discounts, is as follows:

In millions	2020		2021		2022		2023		2024		2025		Thereafter		Total
Loan Notes due 2021	$	—	$	25.0	$	—	$	—	$	—	$	—	$	—	$	25.0
Loan Notes due 2023	—		—		—		25.0		—		—		—		25.0
Loan Notes due 2026	—		—		—		—		—		—		25.0		25.0
Revolving credit facility	—		—		34.7		—		—		—		—		34.7
Total debt	$	—	$	25.0	$	34.7	$	25.0	$	—	$	—	$	25.0	$	109.7

Loan notes due and shelf facility

We have been in compliance with the covenants under the Note Purchase and Private Shelf Agreement throughout all of the quarterly measurement dates from and including September 30, 2014, to March 29, 2020.

The Loan Notes due 2021, 2023 and 2026, the Shelf Facility and the Note Purchase and Private Shelf Agreement are governed by the law of the State of New York.

Senior Facilities Agreement

During the First Quarter of 2020, we drew down $17.2 million on the Revolving Credit Facility and the balance outstanding at March 29, 2020, was $34.7 million, and at December 31, 2019, was $17.5 million, with $115.3 million undrawn at March 29, 2020, $132.5 million at December 31, 2019.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to March 29, 2020.

12

9.    Derivatives and Financial Instruments

The Company's financial instruments comprise bank and other loans, senior loan notes, derivatives, trade payables deferred and deferred contingent consideration. Other than derivatives, the main purpose of these financial instruments is to raise finance for the Company's operations. The Company also has various financial assets such as trade receivables and cash and cash equivalents, which arise directly from its operations.

Derivative financial instruments                                        We are exposed to market risk during the normal course of business from changes in currency exchange rates, interest rates and commodity prices such as aluminum prices. We manage exposures through a combination of normal operating and financing activities and through the use of derivative financial instruments such as foreign currency forward purchase contracts and aluminum forward purchase contracts. We do not use market risk-sensitive instruments for trading or speculative purposes. The Company had $0.4 million and $0.3 million derivative financial instruments disclosed within Accounts and other receivables as of March 29, 2020 and December 31, 2019, respectively. There were also $0.2 million and less than $0.1 million derivative financial instruments recorded in Other current liabilities at March 29, 2020, and December 31, 2019, respectively.

The fair value of forward foreign currency exchange contracts deferred in equity was nil at March 29, 2020, and December 31, 2019, respectively. During the First Quarter of 2020, nothing was transferred to the Income Statement.

Forward foreign currency exchange contracts                                    The Company incurs currency transaction risk whenever one of the Company's operating subsidiaries enters into either a purchase or sales transaction in a currency other than its functional currency. Currency transaction risk is reduced by matching sales and expenses in the same currency. The Company's U.S. operations have little currency exposure, as most purchases, costs and sales are conducted in U.S. dollars. The Company's U.K. operations are exposed to exchange transaction risks, mainly because these operations sell goods priced in euros and U.S. dollars, and purchase raw materials priced in U.S. dollars and its functional currency is GBP sterling. The Company also incurs currency transaction risk if it lends currency other than its functional currency to one of its joint venture partners.

At March 29, 2020, and December 31, 2019, the Company held various forward foreign currency exchange contracts designated as hedges in respect of forward sales for U.S. dollars, euros and Japanese Yen for the receipt of GBP sterling or euros. The Company also held forward foreign currency exchange contracts designated as hedges in respect of forward purchases for U.S. dollars, euros and Canadian dollars by the sale of GBP sterling. The contract totals in GBP sterling, range of maturity dates and range of exchange rates are disclosed below, with the value denominated in GBP sterling given that is the currency the majority of the contracts are held in.

	March 29, 2020
Sales hedges	U.S. dollars	Euros
Contract totals/£m	6.8	9.9
Maturity dates	04/20	04/20 to 06/20
Exchange rates	$1.1617 to $1.2281	€1.1151 to €1.1914

Purchase hedges	U.S. dollars	Euros	Canadian dollars
Contract totals/£m	1.4	0.8	6.8
Maturity dates	04/20 to 06/20	03/20	03/20 to 04/20
Exchange rates	$1.2303 to $1.3132	€1.1663	$1.7018 to $1.7240

	December 31, 2019
Sales hedges	U.S. dollars	Euros	Japanese Yen
Contract totals/£m	0.1	7.6	0.1
Maturity dates	01/20	01/20 to 03/20	01/20
Exchange rates	$1.2914	€1.1551 to €1.1750	JPY 142.86

Purchase hedges	U.S. dollars	Euros	Canadian dollars
Contract totals/£m	1.3	0.8	7.0
Maturity dates	03/20	03/20	01/20
Exchange rates	$1.3228	€1.1663	$1.7137 to $1.7664

The above contracts are held in GBP sterling, therefore the analysis in the table has been given in GBP sterling to avoid any movements as a result of translation.

13

9.    Derivatives and Financial Instruments (continued)

Fair value of financial instruments                                        

The following methods were used to estimate the fair values of each class of financial instrument:

Cash at bank and in hand / overdrafts                                        The carrying value approximates to the fair value as a result of the short-term maturity of the instruments. Cash at bank and in hand are subject to a right to offset in the U.S.

Bank loans                                                    Bank and other loans, excluding overdrafts, of $109.7 million were outstanding at March 29, 2020, and $92.5 million were outstanding at December 31, 2019. Bank and other loans are shown net of issue costs of $0.9 million and $1.1 million at March 29, 2020, and December 31, 2019, respectively, and are to be amortized to the expected maturity of the facilities. Of the bank and other loans outstanding, $34.7 million and $17.5 million is variable interest rate debt and subject to floating interest rate risk, with the remainder being fixed rate debt, at March 29, 2020, and December 31, 2019, respectively.

Forward foreign currency exchange rate contracts                                The fair value of these contracts was calculated by determining what the Company would be expected to receive or pay on termination of each individual contract by comparison to present market prices.

LME derivative contracts                                            The fair value of these contracts has been calculated by valuing the contracts against the equivalent forward rates quoted on the LME.

Deferred contingent consideration                                    

The deferred contingent consideration was in relation to the acquisition of Truetech and Innotech (Luxfer Magtech) in 2014 and was linked to the future profitability of the entity. All consideration in relation to this acquisition has now been paid as at March 29, 2020.

Fair value hierarchy

The Company uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

The fair values of the financial instruments of the Company at March 29, 2020, were analyzed using the hierarchy as follows:

In millions	Total		Level 1		Level 2		Level 3
Derivative financial assets:
Foreign currency contract assets	$	0.4	$	—	$	0.4	$	—
Derivative financial liabilities:
Foreign currency contract liabilities	0.6		—		0.6		—
Interest bearing loans and borrowings:
Loan Notes due 2021	25.0		—		25.0		—
Loan Notes due 2023	25.4		—		25.4		—
Loan Notes due 2026	26.1		—		26.1		—
Revolving Credit Facility	34.7		—		34.7		—

14

9.    Derivatives and Financial Instruments (continued)

The following table presents the changes in Level 3 instruments for the First Quarter ended March 29, 2020.

In millions	2020
Balance at January 1,	$	0.5
Payments made during year	(0.4		)
Release of deferred consideration (recognized in acquisition-related costs)	(0.1		)
Balance at March 29,	$	—
Total credit for the period included in profit and loss for assets held at the end at March 29	(0.1		)
Change in unrealized (gains) or losses for the period included in profit and loss for assets held at the end at March 29,	$	(0.1	)

10.    Income Taxes

We manage our affairs so that we are centrally managed and controlled in the United Kingdom (“U.K.”) and therefore have our tax residency in the U.K. The provision for income taxes consists of provisions for the U.K. and international income taxes. We operate in an international environment with operations in various locations outside the U.K. Accordingly, the consolidated income tax rate is a composite rate reflecting the earnings in the various locations and the applicable rates.

The effective income tax rate for the First Quarter ended March 29, 2020, was 21.5%, compared to negative 131.3% for the First Quarter ended March 31, 2019. The 2019 rate was affected by the impact of non-deductible expenses related to the aborted acquisition of Neo Performance Materials and restructuring activities. The tax rate in any quarter can be affected positively or negatively by adjustments that are required to be reported in the specific quarter of resolution.

11.     Pension Plans

The principal defined benefit pension plan in the U.K. is the Luxfer Group Pension Plan. The Company’s other arrangements are less significant than the Luxfer Group Pension Plan, the largest being the BA Holdings, Inc. Pension Plan in the U.S.

Components of net periodic benefit cost for our pension plans for the First Quarter ended March 29, 2020, and March 31, 2019 were as follows:

	First Quarter
In millions	2020			2019
Net periodic benefit credit
Interest cost	$	2.3		$	2.7
Expected return on plan assets	(3.6		)	(3.8		)
Amortization of:
Net actuarial loss	0.5			0.7
Prior service credit	(0.1		)	(0.1		)
Net periodic benefit credit	$	(0.9	)	$	(0.5	)
In respect of defined contribution plans
Total charge for defined contribution plans	1.1			1.2
Total charge for pension plans	$	0.2		$	0.7

In accordance with ASC 715, defined benefit credit is split in the income statement, with $0.2 million (2019: $0.1 million) of expenses recognized within Selling, general and administrative expenses and a credit of $1.1 million (2019: $0.6 million) recognized below Operating income / (loss) in the income statement.

15

12.    Share Plans

Total share-based compensation expense for the quarters ended March 29, 2020, and March 31, 2019, was as follows:

	First Quarter
In millions	2020		2019
Total share-based compensation charges	$	0.5	$	2.6

In March 2020, we issued our annual share-based compensation grants under the Luxfer Holdings PLC Long-Term Umbrella Incentive Plan. The total number of awards issued was approximately 130,000 and the weighted average fair value of options granted in 2020 was estimated to be $11.30 per share.

The following table illustrates the assumptions used in deriving the fair value of share options granted during the First Quarter of 2020 and the year-ended December 31, 2019:

	2020	2019
Dividend yield (%)	2.10	2.10
Expected volatility range (%)	39.00	35.06 - 44.20
Risk-free interest rate (%)	1.60	0.74 - 2.52
Expected life of share options range (years)	4.00	0.50 - 4.00
Weighted average exercise price ($)	$1.00	$1.00
Model used	Black-Scholes	Black-Scholes & Monte-Carlo

The expected life of the share options is based on historical data and current expectations, and is not necessarily indicative of exercise patterns that may occur. The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.

13.    Shareholders' Equity

(a) Dividends paid and proposed

In millions	2020		2019
Dividends declared and paid during the year:
Interim dividend paid February 6, 2019 ($0.125 per ordinary share)	$	—	$	3.4
Interim dividend paid February 5, 2020 ($0.125 per ordinary share)	3.4		—
	$	3.4	$	3.4

In millions	2020		2019
Dividends declared and paid after the quarter end (not recognized as a liability at the quarter end):
Interim dividend declared April 1, and paid May 1, 2019: ($0.125 per ordinary share)	$	—	$	3.4
Interim dividend declared April 6, and to be paid May 6, 2020: ($0.125 per ordinary share)	3.4		—
	$	3.4	$	3.4

16

14.    Segmental Information

We classify our operations into two core business segments, Gas Cylinders and Elektron, based primarily on shared economic characteristics for the nature of the products and services; the nature of the production processes; the type or class of customer for their products and services; the methods used to distribute their products or provide their services; and the nature of the regulatory environment. The Company has five identified business units, which aggregate into the two reportable segments. Luxfer Gas Cylinders and Luxfer Superform aggregate into the Gas Cylinders segment, and Luxfer MEL Technologies, Luxfer Magtech and Luxfer Graphic Arts aggregate into the Elektron segment. In the first two quarters of 2019, prior to its divestiture, Luxfer Czech Republic also aggregated into the Elektron Segment. A summary of the operations of the segments is provided below:

Gas Cylinders segment

Our Gas Cylinders segment manufactures and markets specialized products using aluminum, titanium and carbon composites, including pressurized cylinders for use in various applications including self-contained breathing apparatus (SCBA) for firefighters, containment of oxygen and other medical gases for healthcare, alternative fuel vehicles, and general industrial. The segment also forms lightweight aluminum and titanium panels into highly complex shapes that are used mainly in the transportation industry.

Elektron segment                                                Our Elektron segment focuses on specialty materials based primarily on magnesium and zirconium, with key product lines including advanced lightweight magnesium alloys with a variety of uses across a variety of industries; magnesium powders for use in countermeasure flares, as well as heater meals; photoengraving plates for graphic arts; and high-performance zirconium-based materials and oxides used as catalysts and in the manufacture of advanced ceramics, fiber-optic fuel cells, and many other performance products.

Other

Other primarily represents unallocated corporate expense and includes non-service related defined benefit pension cost / credit.

Management monitors the operating results of its reportable segments separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated by the chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments as the CEO, using adjusted EBITA⁽¹⁾ and adjusted EBITDA, which we defined as segment income and are based on operating income adjusted for share based compensation charges; loss on disposal of property, plant and equipment, restructuring charges; impairment charges; acquisition and disposal related gains and costs; other charges; depreciation and amortization; and unwind of discount on deferred consideration.

Unallocated assets and liabilities include those which are held on behalf of the Company and cannot be allocated to a segment, such as taxation, investments, cash, retirement benefits obligations, bank and other loans and holding company assets and liabilities.

Financial information by reportable segment for the First Quarter ended March 29, 2020, and March 31, 2019, is included in the following summary:

	Net sales				Adjusted EBITDA
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	52.6	$	58.4	$	3.5	$	4.5
Elektron segment	51.2		62.0		11.6		14.0
Consolidated	$	103.8	$	120.4	$	15.1	$	18.5

	Depreciation and amortization				Restructuring charges
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	1.2	$	1.4	$	2.6	$	8.9
Elektron segment	2.4		2.3		—		0.1
Other	—		—		0.2		—
Consolidated	$	3.6	$	3.7	$	2.8	$	9.0

⁽¹⁾ Adjusted EBITA is adjusted EBITDA less depreciation.

17

14.    Segmental Information (continued)

	Total assets				Capital expenditures
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	156.6	$	156.0	$	0.5	$	1.1
Elektron segment	201.7		200.8		1.1		2.6
Other	34.2		33.5		—		—
	$	392.5	$	390.3	$	1.6	$	3.7

	Property, plant and equipment, net
In millions	2020		2019
United States	$	56.0	$	57.3
United Kingdom	33.7		36.7
Rest of Europe	1.0		1.0
Asia Pacific	0.3		0.3
Other (2)	3.3		3.6
	$	94.3	$	98.9

The following table presents a reconciliation of Adjusted EBITDA to net income:

In millions	2020			2019
Adjusted EBITDA	$	15.1		$	18.5
Other share-based compensation charges	(0.5		)	(2.6		)
Depreciation and amortization	(3.6		)	(3.7		)
Restructuring charges	(2.8		)	(9.0		)
Impairment charges	—			0.2
Acquisition costs	(0.2		)	(4.6		)
Defined benefits pension pension credit	1.1			0.6
Interest expense, net	(1.2		)	(1.1		)
Provision for income taxes	(1.7		)	(2.1		)
Net income	$	6.2		$	(3.8	)

18

14.    Segmental Information (continued)

The following tables present certain geographic information by geographic region for the First Quarter ended March 29, 2020, and March 31, 2019:

	Net Sales(1)
	2020				2019
	$M		Percent		$M		Percent
United States	$	59.7	57.5	%	$	61.4	51.0	%
U.K.	7.4		7.1	%	11.5		9.6	%
Germany	3.6		3.5	%	8.2		6.8	%
Italy	4.4		4.2	%	6.5		5.4	%
France	4.6		4.4	%	5.2		4.3	%
Top five countries	$	79.7	76.8	%	$	92.8	77.1	%
Rest of Europe	7.1		6.8	%	11.8		9.8	%
Asia Pacific	11.5		11.1	%	11.6		9.6	%
Other (2)	5.5		5.3	%	4.2		3.5	%
	$	103.8			$	120.4

(1) Net sales are based on the geographic destination of sale.

(2) Other includes Canada, South America, Latin America and Africa.

15.     Commitments and Contingencies

Committed and uncommited banking facilities

At March 29, 2020, and December 31, 2019, the Company had committed banking facilities of $150.0 million. The facilities were for providing loans, with a with a separate facility for letters of credit which at March 29, 2020, was £1.0 million ($1.2 million) and December 31, 2019, was £1.0 million ($1.3 million). Of the committed facilities, $34.7 million was drawn for loans and no letters of credit were utilized at March 29, 2020, $17.5 million, and nil at December 31, 2019. The Company also has two separate bonding facilities for bank guarantees, one denominated in GBP sterling of £4.5 million (2020: $5.5 million, 2019: $5.9 million), of which £1.6 million (2020: $1.9 million, 2019: $2.3 million) was utilized at March 29, 2020, and December 31, 2019, respectively and one denominated in USD of $0.4 million which was fully utilized at March 29, 2020 and December 31, 2019 respectively. The Company also has a $4.0 million separate overdraft facility of which none was drawn at March 29, 2020, nil and nil at December 31, 2019.

Contingencies

During February 2014, a cylinder was sold to a long-term customer and ruptured at one of their gas facilities. As a result of this rupture, three people were noted to have minor injuries such as loss of hearing. There was no major damage to assets of the customer. A claim was launched by the three people who were injured in the incident. We have reviewed our quality control checks from around the time which the cylinder was produced and no instances of failures have been noted. It has also been noted by the investigator that the customer has poor quality and safety checks. As a result, we do not believe that we are liable for the incident, and therefore, do not currently expect this case to have a material impact on the Company's financial position or results of operations.

16. Subsequent Events

See Impact of COVID-19 on the Financial Statements included within Note 1.

19

Item 2.        Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Interim Report on Form 10-Q contains certain statements, statistics and projections that are, or may be, forward-looking. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Interim Report, as well as:

• general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;

• risks related to the impact of the global COVID-19 pandemic, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, supply chain disruptions and other impacts to the business, and the Company’s ability to execute business continuity plans, as a result of the COVID-19 pandemic;

• worldwide economic and business conditions and conditions in the industries in which we operate;

• fluctuations in the cost of raw materials and utilities;

• currency fluctuations and other financial risks;

• our ability to remediate the material weakness in our internal controls over financial reporting;

• our ability to protect our intellectual property;

• the significant amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;

• relationships with our customers and suppliers;

• increased competition from other companies in the industries in which we operate;

• changing technology;

• claims for personal injury, death or property damage arising from the use of products produced by us;

• the occurrence of accidents or other interruptions to our production processes;

• changes in our business strategy or development plans, and our expected level of capital expenditure;

• our ability to attract and retain qualified personnel;

• restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;

• regulatory, environmental, legislative and judicial developments; and

• our intention to pay dividends.

Please read the sections "Business," "Risk factors," included within the 2019 Annual Report on Form 10-K and "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Risk factors" of this Interim Report on Form 10-Q for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

20

About Luxfer

Luxfer is a global manufacturer of highly-engineered industrial materials, which focuses on value creation by using its broad array of technical knowhow and proprietary technologies. Luxfer's high-performance products are used in defense and emergency response, healthcare, transportation, and general industrial settings. For more information, visit www.luxfer.com.

Key trends and uncertainties regarding our existing business

Impact of COVID-19 on operations

Luxfer’s top priority during this global pandemic is the health and well-being of our employees, customers, shareholders, and the communities in which we operate. The Company continues to monitor the COVID-19 situation closely, while simultaneously executing business continuity plans. These business continuity plans include, but are not limited to, (i) retooling operations to maintain social distance and maximize employee safety; (ii) increasing resources and efforts to satisfy demand from the most impactful parts of our business; (iii) expanding flexible work arrangements and policies, where practical, to maximize employee safety; (iv) increased monitoring of short-term cash flow, including measures to reduce costs and generate cash; and (v) providing regular updates to our shareholders, employees, customers, and suppliers in a transparent and timely manner.

At this time, Luxfer is continuing to operate at the majority of its facilities, as permitted by local authorities. However, due to weaker demand resulting from uncertain economic conditions, potential supply constraints, and the continued spread of COVID-19, Luxfer has temporarily suspended operations at certain facilities and reduced capacity at others. As the situation evolves and if warranted, the Company may suspend or reduce operations at additional facilities.

While the impact of COVID-19 on our first quarter results was relatively limited, we do expect a significant near-term adverse impact on our business. However, the Company has a strong balance sheet, a large existing credit facility and has identified no issues in relation to its financial covenants nor availability of funding for its operations. We continue to lean more about the impact of the COVID-19 pandemic and these assumptions and judgments may change over time

Operating objectives and trends

In 2020, our operating objectives and trends we expect to impact our business include the following:

• Productivity acceleration and growth recovery as we progress towards a lean manufacturing process and more focused and faster innovation.

• Leveraging delivered plant consolidation projects in our Gas Cylinders and Graphic Arts businesses to further reduce fixed costs and safeguard competitiveness.

• Continued focus on developing global talent and implementing a high-performance culture.

• Improved operating cash generation with lower restructuring activity and stronger working capital performance.

• However, any future developments are going to be impacted by the extent that the COVID-19 virus affects our business, including our supply of raw materials and demand for our products.

21

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations for the First Quarter of 2020 and 2019 of Luxfer were as follows:

	First Quarter						% / point change
In millions	2020			2019			2020 v 2019
Net sales	$	103.8		$	120.4		(13.8	)%
Cost of goods sold	(79.3		)	(90.3		)	(12.2	)%
Gross profit	24.5			30.1			(18.6	)%
% of net sales	23.6		%	25.0		%	(1.4	)
Selling, general and administrative expenses	(12.8		)	(16.4		)	(22.0	)%
% of net sales	12.3		%	13.6		%	(1.3	)
Research and development	(0.7		)	(1.4		)	(50.0	)%
% of net sales	0.7		%	1.2		%	(0.5	)
Restructuring charges	(2.8		)	(9.0		)	(68.9	)%
% of net sales	2.7		%	7.5		%	(4.8	)
Impairment charges	—			0.2			n/a
% of net sales	—		%	(0.2		)%	0.2
Acquisition related costs	(0.2		)	(4.6		)	(95.7	)%
% of net sales	0.2		%	(3.8		)%	4.0
Operating income / (loss)	8.0			(1.1		)	n/a
% of net sales	7.7		%	(0.9		)%	8.6
Net interest expense	(1.2		)	(1.1		)	9.1	%
% of net sales	1.2		%	0.9		%	0.3
Defined benefit pension credit	1.1			0.6			83.3	%
% of net sales	1.1		%	0.5		%	0.6
Income / (loss) before income taxes and equity in net income of affiliates	7.9			(1.6		)	n/a
% of net sales	7.6		%	(1.3		)%	8.9
Provision for income taxes	(1.7		)	(2.1		)	(19.0	)%
Effective tax rate	21.5		%	(131.3		)%	152.8
Income / (loss) before equity in net income of affiliates	6.2			(3.7		)	n/a
% of net sales	6.0		%	(3.1		)%	9.1
Equity in income / (loss) of unconsolidated affiliates (net of tax)	—			(0.1		)	n/a
% of net sales	—		%	(0.1		)%	0.1
Net income / (loss)	$	6.2		$	(3.8	)	n/a
% of net sales	6.0		%	(3.2		)%	9.2

22

Net sales

The 13.8% decrease in consolidated net sales in 2020 from 2019 was primarily the result of:

• Decreased sales of zirconium-based industrial and automotive catalysis materials;

• $4.4 million adverse impact following the divestiture of our Czech business in Q2, 2019;

• Lower Superform tooling and formed part sales, predominantly to European luxury automotive customers; and

• Decreased sales of lower margin aluminum cylinders.

These decreases were partially offset by continued growth in sales of alternative fuel (AF) cylinders.

Gross profit

The 1.4 percentage point decrease in gross profit as a percentage of sales in 2020 from 2019 was primarily the result of adverse product sales mix, especially the impact of lower sales of zirconium catalysis products in the current quarter.

These adverse factors were partially offset by the impact of productivity improvements in Luxfer Gas Cylinders Europe, following closure of the French operation in 2019 and transfer of production to the U.K.

Selling, general and administrative expenses ("SG&A")

The 1.3 percentage point decrease in SG&A costs as a percentage of sales in 2020 from 2019 was primarily the result of lower share-based compensation charges as well as the impact of further cost savings linked to our cost reduction program.

Research and development costs

Research and development cost as a percentage of sales reduced by 0.5 percentage points in 2020 relative to 2019.

Restructuring charges

The $2.8 million restructuring charge in 2020 was predominantly ($2.6 million) the result of further costs associated with the announced closure of Luxfer Gas Cylinders France, including one-time employee benefits, and associated legal and professional fees.

The $9.0 million restructuring charge in 2019 was mainly ($8.9 million) the result of costs associated with the announced closure of Luxfer Gas Cylinders France, including one-time employee benefits, asset write-offs, and associated legal and professional fees.

Impairment charges

The impairment credit of $0.2 million in 2019 reflects a fair value adjustment to the held-for-sale assets in the Elektron segment.

Acquisition-related costs

Acquisition-related costs of $0.2 million in 2020 represents amounts incurred in relation to M&A exploration activities net of a $0.1 million release of deferred contingent consideration.

Acquisition-related costs of $4.6 million in 2019 relate to a $3.5 million termination payment and our professional and legal fees incurred in connection with the aborted acquisition of Neo Performance Materials.

Net interest expense

The 9.1% increase in net interest expense in 2020 from 2019 was due to the increase in the average debt balance as a result of increased draw down on the revolving credit facility.

23

Defined benefit pension credit

The $0.5 million increase in defined benefit pension credit to $1.1 million in 2020 from $0.6 million in 2019 is primarily due to the combined effect on the U.K. plan of a fall in the discount rate and lower inflation, partially offset by lower projected asset returns.

Provision for income taxes

The movement in the statutory effective tax rate from negative 131.3% in 2019, to 21.5% in 2020, was primarily due to non-deductible expenses related to the aborted acquisition and restructuring activities in the prior year. When stripping out the effect of these expenses, our adjusted effective tax rate has remained flat at 20.0% in 2020 (20.0% in 2019).

24

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GAAP MEASURES

The following table of non-GAAP summary financial data presents a reconciliation of net income to adjusted net income for the periods presented, being the most comparable GAAP measure. Management believes that adjusted net income, adjusted earnings per share, adjusted EBITA and adjusted EBITDA are key performance indicators (KPIs) used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. In addition, Luxfer's CEO and other senior management use these KPIs, among others, to evaluate business performance. However, investors should not consider adjusted net income and adjusted earnings per share in isolation as an alternative to net income and earnings per share when evaluating Luxfer's operating performance or measuring Luxfer's profitability.

	First Quarter
In millions except per share data	2020			2019
Net income / (loss)	$	6.2		$	(3.8	)
Accounting charges relating to acquisitions and disposals of businesses:
Amortization on acquired intangibles	0.2			0.3
Acquisition costs	0.2			4.6
Defined benefit pension credit	(1.1		)	(0.6		)
Restructuring charges	2.8			9.0
Impairment charges	—			(0.2		)
Share-based compensation charges	0.5			2.6
Income tax on adjusted items	(0.4		)	(0.7		)
Adjusted net income	$	8.4		$	11.2
Adjusted earnings per ordinary share
Diluted earnings / (loss) per ordinary share	$	0.22		$	(0.14	)
Impact of adjusted items	0.08			0.54
Adjusted diluted earnings per ordinary share(1)	$	0.30		$	0.40

⁽¹⁾ For the purpose of calculating diluted earnings per share, the weighted average number of ordinary shares outstanding during the financial year has been adjusted for the dilutive effects of all potential ordinary shares and share options granted to employees, except where there is a loss in the period, then no adjustment is made.

	First Quarter
In millions	2020		2019
Adjusted net income	$	8.4	$	11.2
Add back:
Income tax on adjusted items	0.4		0.7
Provision for income taxes	1.7		2.1
Net finance costs	1.2		1.1
Adjusted EBITA	$	11.7	$	15.1
Depreciation	3.4		3.4
Adjusted EBITDA	$	15.1	$	18.5

25

The following table presents a reconciliation for the adjusted effective tax rate, which management believes is a KPI used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results.

	First Quarter
In millions	2020			2019
Adjusted net income	$	8.4		$	11.2
Add back:
Income tax on adjusted items	0.4			0.7
Provision for income taxes	1.7			2.1
Adjusted income before income taxes	$	10.5		$	14.0
Adjusted provision for income taxes	2.1			2.8
Adjusted effective tax rate	20.0		%	20.0		%

SEGMENT RESULTS OF OPERATIONS

The summary that follows provides a discussion of the results of operations of each of our two reportable segments (Gas Cylinders and Elektron). Both segments comprise various product offerings that serve multiple end markets.

Adjusted EBITDA represents operating income adjusted for share based compensation charges; loss on disposal of property, plant and equipment, restructuring charges; impairment charges; acquisition and disposal related gains and costs; other charges; depreciation and amortization; and unwind of discount on deferred consideration. A reconciliation to net income and taxes can be found in Note 14 to the condensed consolidated financial statements.

GAS CYLINDERS

The net sales and adjusted EBITDA for Gas Cylinders were as follows:

	First Quarter						% / point change
In millions	2020			2019			2020 v 2019
Net sales	$	52.6		$	58.4		(9.9	)%
Adjusted EBITDA	3.5			4.5			(22.2	)%
% of net sales	6.7		%	7.7		%	(1.0	)

Net sales

The 9.9% decrease in Gas Cylinders sales in 2020 from 2019 was primarily the result of:

• Decreased sales of Superform tooling and formed parts;

• Decreased sales of aluminum cylinders.

These decreases were partially offset by continued growth in sales of AF cylinders.

Adjusted EBITDA

The 1.0 percentage point decrease in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2020 from 2019 was primarily the result of adverse product mix partially offset by productivity improvements at Luxfer Gas Cylinders Europe (as explained above).

26

ELEKTRON

The net sales and adjusted EBITDA for Elektron were as follows:

	First Quarter						% / point change
In millions	2020			2019			2019 v 2018
Net sales	$	51.2		$	62.0		(17.4	)%
Adjusted EBITDA	11.6			14.0			(17.1	)%
% of net sales	22.7		%	22.6		%	0.1

Net sales

The 17.4% increase in Elektron sales in 2020 from 2019 was primarily the result of:

• Decreased sales of zirconium-based industrial and automotive catalysts; and

• $4.4 million adverse impact following the divestiture of our Czech business in Q2, 2019.

Adjusted EBITDA

The 0.1 percentage point increase in adjusted EBITDA for Elektron as a percentage of net sales in 2020 from 2019 was primarily the result of a slight improvement in product sales mix following divestiture of the lower margin Czech recycling business in Q2, 2019.

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity requirements arise primarily from obligations under our indebtedness, capital expenditures, acquisitions, the funding of working capital and the funding of hedging facilities to manage foreign exchange and commodity purchase price risks. We meet these requirements primarily through cash flows from operating activities, cash deposits and borrowings under the Revolving Credit Facility and accompanying ancillary hedging facilities and the Loan Notes due, 2021, 2023 and 2026. Our principal liquidity needs are:

• funding acquisitions, including deferred contingent consideration payments;

• capital expenditure requirements;

• payment of shareholder dividends;

• servicing interest on the Loan Notes, which is payable at each quarter end, in addition to interest and / or commitment fees on the Senior Facilities Agreement;

• working capital requirements, particularly in the short term as we aim to achieve organic sales growth; and

• hedging facilities used to manage our foreign exchange and aluminum purchase price risks.

From time to time, we consider acquisitions or investments in other businesses that we believe would be appropriate additions to our business.

We believe that, in the long term, cash generated from our operations will be adequate to meet our anticipated requirements for working capital, capital expenditures and interest payments on our indebtedness. In the short term, we believe we have sufficient credit facilities to cover any variation in our cash flow generation. However, any major repayments of indebtedness will be dependent on our ability to raise alternative financing or to realize substantial returns from operational sales. Also, our ability to expand operations through sales development and capital expenditures could be constrained by the availability of liquidity, which, in turn, could impact the profitability of our operations.

27

We have been in compliance with the covenants under the Loan Notes and the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to March 29, 2020.

Luxfer conducts all of its operations through its subsidiaries, joint ventures and affiliates. Accordingly, Luxfer's main cash source is dividends from its subsidiaries. The ability of each subsidiary to make distributions depends on the funds that a subsidiary receives from its operations in excess of the funds necessary for its operations, obligations or other business plans. We have not historically experienced any material impediment to these distributions, and we do not expect any local legal or regulatory regimes to have any impact on our ability to meet our liquidity requirements in the future. In addition, since our subsidiaries are wholly-owned, our claims will generally rank junior to all other obligations of the subsidiaries. If our operating subsidiaries are unable to make distributions, our growth may slow, unless we are able to obtain additional debt or equity financing. In the event of a subsidiary's liquidation, there may not be assets sufficient for us to recoup our investment in the subsidiary.

Our ability to maintain or increase the generation of cash from our operations in the future will depend significantly on the competitiveness of and demand for our products, including our success in launching new products. Achieving such success is a key objective of our business strategy. Due to commercial, competitive and external economic factors, however, we cannot guarantee that we will generate sufficient cash flows from operations or that future working capital will be available in an amount sufficient to enable us to service our indebtedness or make necessary capital expenditures.

Cash Flows

Operating activities

Cash used in operating activities was $4.5 million in the first quarter of 2020. It was primarily related to net income from operating activities, net of the following non-cash items: depreciation and amortization, pension contributions and net changes to assets and liabilities.

Cash used in operating activities was $7.8 million in the first quarter of 2019. It was primarily related to net loss from operating activities, net of the following non-cash items: depreciation and amortization; asset impairment charges, pension contributions and net changes to assets and liabilities.

Investing activities

Net cash used for investing activities was $2.5 million in the first quarter of 2020, compared to net cash used for investing activities of $3.2 million in the first quarter of 2019. The movement was primarily due to a decrease in capital expenditures which were $2.5 million and $3.2 million, in the first quarter of 2020, and 2019, respectively. We anticipate capital expenditures for fiscal 2020 to be approximately $10 million to $12 million.

Financing activities

In 2020, net cash provided from financing activities was $14.5 million (2019: $11.2 million inflow). We made net drawdowns on our banking facilities of $18.9 million (2019: $15.5 million drawdown) and dividend payments of $3.4 million (2019: $3.4 million), equating to $0.125 per ordinary share. We received $0.1 million (2019: $1.4 million) in relation to proceeds from sales of shares.

Capital Resources

Dividends

We paid dividends in the first quarter of 2020 of $3.4 million (2019: $3.4 million), or $0.50 per ordinary share.

Any payment of dividends is also subject to the provisions of the U.K. Companies Act, according to which dividends may only be paid out of profits available for distribution determined by reference to financial statements prepared in accordance with the Companies Act and IFRS as adopted by the E.U., which differ in some respects from GAAP. In the event that dividends are paid in the future, holders of the ordinary shares will be entitled to receive payments in U.S. dollars in respect of dividends on the underlying ordinary shares in accordance with the deposit agreement. Furthermore, because we are a holding company, any dividend payments would depend on cash flows from our subsidiaries.

Authorized shares

Our authorized share capital consists of 40.0 million ordinary shares with a par value of £0.50 per share.

28

Contractual obligations

The following summarizes our significant contractual obligations that impact our liquidity:

	Payments Due by Period
	Total		Less than 1 year		1 – 3 years		3 – 5 years		After 5 years
	(in $ million)
Contractual cash obligations
Loan Notes due 2021	$	25.0	$	—	$	25.0	$	—	$	—
Loan Notes due 2023	25.0		—		—		25.0		—
Loan Notes due 2026	25.0		—		—		—		25.0
Revolving credit facility	34.7		—		34.7		—		—
Obligations under operating leases	20.6		3.7		4.9		2.9		9.1
Capital commitments	0.8		0.8		—		—		—
Interest payments	13.1		3.4		5.4		2.8		1.5
Total contractual cash obligations	$	144.2	$	7.9	$	70.0	$	30.7	$	35.6

Off-balance sheet measures

At March 29, 2020, we had no off-balance sheet arrangements.

NEW ACCOUNTING STANDARDS

See Note 1 of the Notes to Condensed Consolidated Financial Statements for information pertaining to recently adopted accounting standards or accounting standards to be adopted in the future.

CRITICAL ACCOUNTING POLICIES

We have adopted various accounting policies to prepare the consolidated financial statements in accordance with GAAP. Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. In our 2019 Annual Report on Form 10-K, filed with the SEC on March 9, 2020, we identified the critical accounting policies which affect our more significant estimates and assumptions used in preparing our consolidated financial statements.

29

Item 3.        Quantitative and qualitative disclosures about market risk

There have been no material changes in our market risk during the quarter ended March 29, 2020 except for the impact of COVID-19, which is addressed as a specific risk factor in ITEM-1A in Part II of this filing. For additional information, refer to Item 7A of our 2019 Annual Report on Form 10-K, filed with the SEC on March 9, 2020.

Item 4.        Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures designed to provide reasonable assurance as to the reliability of our published financial statements and other disclosures included in this report. Our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter ended March 29, 2020, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 29, 2020, as a result of the material weakness described in Item 9A of the Form 10-K filed with the SEC on March 9, 2020 not having been fully remediated by the first quarter of 2020.

In light of the material weakness, the Company performed additional analysis and other post-closing procedures to ensure our consolidated financial statements are prepared in accordance with generally accepted accounting principles. Our management, including our Chief Executive Officer and our Chief Financial Officer, has concluded that our consolidated financial statements for the periods covered by and included in this Quarterly Report on Form 10-Q are fairly presented in all material respects in accordance with accounting principles generally accepted in the United States of America (GAAP) for the periods presented herein.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter and annual period ended March 29, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

30

PART II - OTHER INFORMATION

Item 1.        Legal Proceedings

While we are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, employee and product liability claims, there are no material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject. It is possible, however, that an adverse resolution of an unexpectedly large number of such individual claims or proceedings could in the aggregate have a material adverse effect on results of operations for a particular year or quarter.

Item 1A.    Risk Factors

There have been no material changes from the risk factors previously disclosed in Item 1A. of our 2019 Annual Report on Form 10-K, except that the adverse impact of the COVID-19 coronavirus outbreak has become more significant and widespread. The related risk factors under the caption "We depend upon our larger suppliers for a significant portion of our raw materials, and a loss of one of these suppliers, or a significant supply interruption could negatively impact our financial performance" as previously disclosed in Item 1A. of our 2019 Annual Report on Form 10-K relating to COVID-19, remain applicable. In addition to the supply-side risks there are additional risks related to a fall in customer demand. We therefore highlight the following additional risk.

Our results of operations may be negatively impacted by the coronavirus disease pandemic

In December 2019, the 2019 novel coronavirus disease (COVID-19) surfaced in Wuhan, China. In March 2020, the World Health Organization characterized the coronavirus ("COVID-19") a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the pandemic and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy, resulting in an economic downturn that could impact demand for our products. With many countries in 'lockdown', non-essential manufacturers and suppliers have been forced to shut down operations. This has caused disruptions from the temporary closure of third-party supplier and manufacturer facilities and interruptions in product supply. Disruption to our suppliers and falling demand from our customers will likely impact our sales and operating results. To date the outbreak has not had a material adverse impact on our operations, however the future impact is highly uncertain and cannot be predicted and there is no assurance that the outbreak will not have a material adverse impact on the future results of the Company. The extent of the impact will depend on future developments, including global and country-specific actions taken to contain the spread of the coronavirus.

Item 2.        Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

31

Item 6.    Exhibits

31.1 Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934-Alok Maskara

31.2 Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934-Heather Harding

32.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)-Alok Maskara

32.2 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)-Heather Harding

101 The financial statements from the Company’s Interim Report on Form 10-Q for the quarter ended March 29, 2020, formatted in XBRL: (i) Condensed Consolidated Statements of Income, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of Changes in Equity, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.

32

SIGNATURES

Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Luxfer Holdings plc

(Registrant)

/s/Alok Maskara

Alok Maskara

Chief Executive Officer

(Duly Authorized Officer)

April 27, 2020

33

EX-31.1

Section 302 Certificate

Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Alok Maskara, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Luxfer Holdings PLC;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2020	__/s/ Alok Maskara____________________
	Alok Maskara Chief Executive Officer

EX-31.2

Section 302 Certificate

Certification Required by Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Heather Harding, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Luxfer Holdings PLC;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2020	__/s/Heather Harding___________________
	Heather Harding Chief Financial Officer

EX-32.1

Section 906 Certificate

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Alok Maskara, the Chief Executive Officer of Luxfer Holdings PLC, a public limited company incorporated under English law (the “Company”), do hereby certify, to my knowledge, that:

• the Quarterly Report on Form 10-Q for the period ended March 29, 2020 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

• information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 27, 2020 __/s/Alok Maskara____________________ Alok Maskara Chief Executive Officer

EX-32.2

Section 906 Certificate

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Heather Harding, the Chief Financial Officer of Luxfer Holdings PLC, a public limited company incorporated under English law (the “Company”), do hereby certify, to my knowledge, that:

• the Quarterly Report on Form 10-Q for the period ended March 29, 2020 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

• information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 27, 2020 __/s/ Heather Harding__________________ Heather Harding Chief Financial Officer

XML

Revenue - Contract Receivables, Contract Assets, and Contract Liabilities (Details) - USD ($) $ in Millions	Mar. 29, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Contract receivables	$ 1.5	$ 1.7
Contract assets	0.5	1.3
Contract liabilities	$ (0.4)	$ (0.5)

XML

Basis of Presentation and Responsibility for interim Financial Statements Allowance for Credit Loss Rollforward (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Jan. 01, 2020
Financing Receivable, Allowance for Credit Losses [Line Items]
Provisions for expected credit losses	$ 0.7
Other, including foreign currency translation	(0.1)
Financing receivable, allowance for credit losses, ending balance	1.9
ASU 2016-03
Financing Receivable, Allowance for Credit Losses [Line Items]
Financing receivable, allowance for credit losses, beginning balance	1.3
Adoption of ASU 2016-13, cumulative-effect adjustment to retained earnings		$ 0.0
Financing receivable, allowance for credit losses, ending balance	$ 1.9

XML

Restructuring Reserve (Details) $ in Millions	3 Months Ended
	Mar. 29, 2020 USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 6.5
Costs incurred	2.8
Cash payments and other	(2.4)
Ending balance	$ 6.9

XML

Pension Plans - Schedule of Net Benefit Costs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Retirement Benefits [Abstract]
Interest cost	$ 2.3	$ 2.7
Expected return on plan assets	(3.6)	(3.8)
Amortization of net actuarial loss	0.5	0.7
Amortization of prior service credit	(0.1)	(0.1)
Net periodic benefit credit	(0.9)	(0.5)
Total charge for defined contribution plans	1.1	1.2
Total charge for pension plans	$ 0.2	$ 0.7

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) (Parenthetical) - shares	Mar. 29, 2020	Dec. 31, 2019	Dec. 31, 2017
Ordinary shares
Common stock, shares outstanding (in shares)	29,000,000	29,000,000	29,000,000
Deferred shares
Common stock, shares outstanding (in shares)	761,835,338,444	761,835,338,444	761,835,338,444

XML

Share Plans - Share Options Fair Value Assumptions (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 29, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield (%)	2.10%	2.10%
Expected volatility range (%), minimum	39.00%	35.06%
Expected volatility range (%), maximum		44.20%
Risk-free interest rate (%), minimum	1.60%	0.74%
Risk-free interest rate (%), maximum		2.52%
Expected life of share options range (years)	4 years
Weighted average exercise price (in USD per share)	$ 1.00	$ 1.00
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life of share options range (years)		6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life of share options range (years)		4 years

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Mar. 29, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 17.3	$ 10.2
Restricted cash	0.1	0.1
Accounts and other receivables, net of allowances of $1.9 and $1.3, respectively	73.6	66.3
Inventories	93.9	94.5
Other current assets	4.1	5.0
Total current assets	189.0	176.1
Non-current assets
Property, plant and equipment, net	94.3	98.9
Right-of-use assets from operating leases	13.5	14.8
Goodwill	66.2	68.8
Intangibles, net	13.0	13.6
Deferred tax assets	14.4	15.8
Investments and loans to joint ventures and other affiliates	2.1	2.3
Total assets	392.5	390.3
Current liabilities
Accounts payable	31.6	36.4
Accrued liabilities	24.8	25.2
Taxes on income	0.6	0.1
Other current liabilities	12.2	12.3
Total current liabilities	69.2	74.0
Non-current liabilities
Long-term debt	108.8	91.4
Pensions and other retirement benefits	30.4	35.2
Deferred tax liabilities	2.6	2.5
Other non-current liabilities	11.7	12.8
Total liabilities	222.7	215.9
Shareholders' equity
Additional paid-in capital	68.2	68.4
Treasury shares	(4.0)	(4.0)
Own shares held by ESOP	(1.6)	(1.7)
Retained earnings	87.6	84.8
Accumulated other comprehensive loss	(156.9)	(149.6)
Total shareholders' equity	169.8	174.4
Total liabilities and shareholders' equity	392.5	390.3
Ordinary shares
Shareholders' equity
Common stock	26.6	26.6
Deferred shares
Shareholders' equity
Common stock	$ 149.9	$ 149.9

XML

Document and Entity Information	3 Months Ended
	Mar. 29, 2020 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 29, 2020
Document Transition Report	false
Entity File Number	001-35370
Entity Registrant Name	Luxfer Holdings PLC
Entity Incorporation, State or Country Code	X0
Entity Tax Identification Number	98-1024030
Entity Address, Address Line One	Lumns Lane
Entity Address, City or Town	Manchester
Entity Address, Postal Zip Code	M27 8LN
Country Region	+1
City Area Code	414
Local Phone Number	269-2419
Title of 12(b) Security	Ordinary Shares, nominal value £0.50 each
Trading Symbol	LXFR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	27,500,415
Entity Central Index Key	0001096056
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Address, Country	GB

XML

Revenue (Tables)

3 Months Ended

Mar. 29, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

Disaggregated sales disclosures for the quarter ended March 29, 2020, and March 31, 2019, are included below and in Note 14, Segmental Information.

	First Quarter
	2020						2019
In millions	Gas Cylinders		Elektron		Total		Gas Cylinders		Elektron		Total
General industrial	$	11.9	$	27.7	$	39.6	$	13.1	$	30.6	$	43.7
Transportation	18.9		11.2		30.1		20.9		19.1		40.0
Defense and emergency	18.1		11.4		29.5		18.7		10.5		29.2
Healthcare	3.7		0.9		4.6		5.7		1.8		7.5
	$	52.6	$	51.2	$	103.8	$	58.4	$	62.0	$	120.4

Schedule of Contract Assets and Liabilities

Significant changes in contract liabilities balances during the period are as follows:

In millions	2020
As at January 1,	$	(0.5	)
Net (payments received) / amounts billed	(0.1		)
Net (costs incurred) / revenue recognized	0.2
As at March 29,	$	(0.4	)

The following table provides information about contract receivables, contract assets and contract liabilities from contracts with customers:

In millions	March 29, 2020			December 31, 2019
Contract receivables	$	1.5		$	1.7
Contract assets	0.5			1.3
Contract liabilities	(0.4		)	(0.5		)

XML

Share Plans

3 Months Ended

Mar. 29, 2020

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share Plans

Share Plans

Total share-based compensation expense for the quarters ended March 29, 2020, and March 31, 2019, was as follows:

	First Quarter
In millions	2020		2019
Total share-based compensation charges	$	0.5	$	2.6

In March 2020, we issued our annual share-based compensation grants under the Luxfer Holdings PLC Long-Term Umbrella Incentive Plan. The total number of awards issued was approximately 130,000 and the weighted average fair value of options granted in 2020 was estimated to be $11.30 per share.

The following table illustrates the assumptions used in deriving the fair value of share options granted during the First Quarter of 2020 and the year-ended December 31, 2019:

	2020	2019
Dividend yield (%)	2.10	2.10
Expected volatility range (%)	39.00	35.06 - 44.20
Risk-free interest rate (%)	1.60	0.74 - 2.52
Expected life of share options range (years)	4.00	0.50 - 4.00
Weighted average exercise price ($)	$1.00	$1.00
Model used	Black-Scholes	Black-Scholes & Monte-Carlo

The expected life of the share options is based on historical data and current expectations, and is not necessarily indicative of exercise patterns that may occur. The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.

XML

Subsequent Events

3 Months Ended

Mar. 29, 2020

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

See Impact of COVID-19 on the Financial Statements included within Note 1.

XML

Restructuring

3 Months Ended

Mar. 29, 2020

Restructuring and Related Activities [Abstract]

Restructuring

Restructuring

During the First Quarter of 2020 we continued execution of certain business restructuring initiatives aimed at reducing our fixed cost structure and realigning our business.The $2.8 million restructuring charge in 2020 was predominantly ($2.6 million) the result of further costs associated with the announced closure of Luxfer Gas Cylinders France, including one-time employee benefits, and associated legal and professional fees.

Restructuring-related costs included within Restructuring charges in the Condensed Consolidated Financial Statements by reportable segment were as follows:

	First Quarter
In millions	2020		2019
Severance and related costs
Gas Cylinders segment	$	2.6	$	8.9
Elektron segment	—		0.1
Other	0.2		—
Total restructuring charges	$	2.8	$	9.0

Activity related to restructuring, recorded in Other current liabilities in the consolidated balance sheets is summarized as follows:

In millions	2020
Balance at January 1,	$	6.5
Costs incurred	2.8
Cash payments and other	(2.4		)
Balance at March 29,	$	6.9

XML

Debt

3 Months Ended

Mar. 29, 2020

Debt Disclosure [Abstract]

Debt

Debt

Debt outstanding was as follows:

In millions	March 29, 2020			December 31, 2019
3.67% Loan Notes due 2021	$	25.0		$	25.0
4.88% Loan Notes due 2023	25.0			25.0
4.94% Loan Notes due 2026	25.0			25.0
Revolving credit facility	34.7			17.5
Unamortized debt issuance costs	(0.9		)	(1.1		)
Total debt	$	108.8		$	91.4
Less current portion	$	—		$	—
Non-current debt	$	108.8		$	91.4

The weighted-average interest rate on the revolving credit facility was 2.32% for the First Quarter of 2020 and 2.47% for the full-year 2019.

The maturity profile of the Company's debt, excluding unamortized issuance costs and discounts, is as follows:

In millions	2020		2021		2022		2023		2024		2025		Thereafter		Total
Loan Notes due 2021	$	—	$	25.0	$	—	$	—	$	—	$	—	$	—	$	25.0
Loan Notes due 2023	—		—		—		25.0		—		—		—		25.0
Loan Notes due 2026	—		—		—		—		—		—		25.0		25.0
Revolving credit facility	—		—		34.7		—		—		—		—		34.7
Total debt	$	—	$	25.0	$	34.7	$	25.0	$	—	$	—	$	25.0	$	109.7

Loan notes due and shelf facility

We have been in compliance with the covenants under the Note Purchase and Private Shelf Agreement throughout all of the quarterly measurement dates from and including September 30, 2014, to March 29, 2020.

The Loan Notes due 2021, 2023 and 2026, the Shelf Facility and the Note Purchase and Private Shelf Agreement are governed by the law of the State of New York.

Senior Facilities Agreement

During the First Quarter of 2020, we drew down $17.2 million on the Revolving Credit Facility and the balance outstanding at March 29, 2020, was $34.7 million, and at December 31, 2019, was $17.5 million, with $115.3 million undrawn at March 29, 2020, $132.5 million at December 31, 2019.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to March 29, 2020.

XML

Derivatives and Financial Instruments (Tables)

3 Months Ended

Mar. 29, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

	March 29, 2020
Sales hedges	U.S. dollars	Euros
Contract totals/£m	6.8	9.9
Maturity dates	04/20	04/20 to 06/20
Exchange rates	$1.1617 to $1.2281	€1.1151 to €1.1914

Purchase hedges	U.S. dollars	Euros	Canadian dollars
Contract totals/£m	1.4	0.8	6.8
Maturity dates	04/20 to 06/20	03/20	03/20 to 04/20
Exchange rates	$1.2303 to $1.3132	€1.1663	$1.7018 to $1.7240

	December 31, 2019
Sales hedges	U.S. dollars	Euros	Japanese Yen
Contract totals/£m	0.1	7.6	0.1
Maturity dates	01/20	01/20 to 03/20	01/20
Exchange rates	$1.2914	€1.1551 to €1.1750	JPY 142.86

Purchase hedges	U.S. dollars	Euros	Canadian dollars
Contract totals/£m	1.3	0.8	7.0
Maturity dates	03/20	03/20	01/20
Exchange rates	$1.3228	€1.1663	$1.7137 to $1.7664

Schedule of fair values of the financial instruments

The fair values of the financial instruments of the Company at March 29, 2020, were analyzed using the hierarchy as follows:

In millions	Total		Level 1		Level 2		Level 3
Derivative financial assets:
Foreign currency contract assets	$	0.4	$	—	$	0.4	$	—
Derivative financial liabilities:
Foreign currency contract liabilities	0.6		—		0.6		—
Interest bearing loans and borrowings:
Loan Notes due 2021	25.0		—		25.0		—
Loan Notes due 2023	25.4		—		25.4		—
Loan Notes due 2026	26.1		—		26.1		—
Revolving Credit Facility	34.7		—		34.7		—

Schedule of changes in Level 3 instruments

The following table presents the changes in Level 3 instruments for the First Quarter ended March 29, 2020.

In millions	2020
Balance at January 1,	$	0.5
Payments made during year	(0.4		)
Release of deferred consideration (recognized in acquisition-related costs)	(0.1		)
Balance at March 29,	$	—
Total credit for the period included in profit and loss for assets held at the end at March 29	(0.1		)
Change in unrealized (gains) or losses for the period included in profit and loss for assets held at the end at March 29,	$	(0.1	)

XML

Restructuring (Tables)

3 Months Ended

Mar. 29, 2020

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs

Restructuring-related costs included within Restructuring charges in the Condensed Consolidated Financial Statements by reportable segment were as follows:

	First Quarter
In millions	2020		2019
Severance and related costs
Gas Cylinders segment	$	2.6	$	8.9
Elektron segment	—		0.1
Other	0.2		—
Total restructuring charges	$	2.8	$	9.0

Schedule of Restructuring Reserve

Activity related to restructuring, recorded in Other current liabilities in the consolidated balance sheets is summarized as follows:

In millions	2020
Balance at January 1,	$	6.5
Costs incurred	2.8
Cash payments and other	(2.4		)
Balance at March 29,	$	6.9

XML

Segmental Information (Tables)

3 Months Ended

Mar. 29, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Financial information by reportable segment for the First Quarter ended March 29, 2020, and March 31, 2019, is included in the following summary:

	Net sales				Adjusted EBITDA
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	52.6	$	58.4	$	3.5	$	4.5
Elektron segment	51.2		62.0		11.6		14.0
Consolidated	$	103.8	$	120.4	$	15.1	$	18.5

	Depreciation and amortization				Restructuring charges
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	1.2	$	1.4	$	2.6	$	8.9
Elektron segment	2.4		2.3		—		0.1
Other	—		—		0.2		—
Consolidated	$	3.6	$	3.7	$	2.8	$	9.0

⁽¹⁾ Adjusted EBITA is adjusted EBITDA less depreciation.

14.    Segmental Information (continued)

	Total assets				Capital expenditures
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	156.6	$	156.0	$	0.5	$	1.1
Elektron segment	201.7		200.8		1.1		2.6
Other	34.2		33.5		—		—
	$	392.5	$	390.3	$	1.6	$	3.7

	Property, plant and equipment, net
In millions	2020		2019
United States	$	56.0	$	57.3
United Kingdom	33.7		36.7
Rest of Europe	1.0		1.0
Asia Pacific	0.3		0.3
Other (2)	3.3		3.6
	$	94.3	$	98.9

Property, plant and equipment, net by geographic region

	Property, plant and equipment, net
In millions	2020		2019
United States	$	56.0	$	57.3
United Kingdom	33.7		36.7
Rest of Europe	1.0		1.0
Asia Pacific	0.3		0.3
Other (2)	3.3		3.6
	$	94.3	$	98.9

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

The following table presents a reconciliation of Adjusted EBITDA to net income:

In millions	2020			2019
Adjusted EBITDA	$	15.1		$	18.5
Other share-based compensation charges	(0.5		)	(2.6		)
Depreciation and amortization	(3.6		)	(3.7		)
Restructuring charges	(2.8		)	(9.0		)
Impairment charges	—			0.2
Acquisition costs	(0.2		)	(4.6		)
Defined benefits pension pension credit	1.1			0.6
Interest expense, net	(1.2		)	(1.1		)
Provision for income taxes	(1.7		)	(2.1		)
Net income	$	6.2		$	(3.8	)

Revenue from External Customers and Long-term Assets by Geographic Areas

The following tables present certain geographic information by geographic region for the First Quarter ended March 29, 2020, and March 31, 2019:

	Net Sales(1)
	2020				2019
	$M		Percent		$M		Percent
United States	$	59.7	57.5	%	$	61.4	51.0	%
U.K.	7.4		7.1	%	11.5		9.6	%
Germany	3.6		3.5	%	8.2		6.8	%
Italy	4.4		4.2	%	6.5		5.4	%
France	4.6		4.4	%	5.2		4.3	%
Top five countries	$	79.7	76.8	%	$	92.8	77.1	%
Rest of Europe	7.1		6.8	%	11.8		9.8	%
Asia Pacific	11.5		11.1	%	11.6		9.6	%
Other (2)	5.5		5.3	%	4.2		3.5	%
	$	103.8			$	120.4

(1) Net sales are based on the geographic destination of sale.

(2) Other includes Canada, South America, Latin America and Africa.

XML

Derivatives and Financial Instruments - Schedule of Derivative Instruments (Details) - Designated as Hedging Instrument ¥ in Millions, £ in Millions	Mar. 29, 2020 GBP (£) € / £ $ / £ $ / £	Dec. 31, 2019 GBP (£) € / £ ¥ / £ $ / £ $ / £	Dec. 31, 2019 JPY (¥) € / £ ¥ / £ $ / £ $ / £
U.S. dollars | Sales hedges
Derivative [Line Items]
Contract totals/£m | £	£ 6.8	£ 0.1
Exchange rates		1.2914	1.2914
U.S. dollars | Sales hedges | Minimum
Derivative [Line Items]
Exchange rates	1.1617
U.S. dollars | Sales hedges | Maximum
Derivative [Line Items]
Exchange rates	1.2281
U.S. dollars | Purchase hedges
Derivative [Line Items]
Contract totals/£m | £	£ 1.4	£ 1.3
Exchange rates		1.3228	1.3228
U.S. dollars | Purchase hedges | Minimum
Derivative [Line Items]
Exchange rates	1.2303
U.S. dollars | Purchase hedges | Maximum
Derivative [Line Items]
Exchange rates	1.3132
Euros | Sales hedges
Derivative [Line Items]
Contract totals/£m | £	£ 9.9	£ 7.6
Euros | Sales hedges | Minimum
Derivative [Line Items]
Exchange rates | € / £	1.1151	1.5510	1.5510
Euros | Sales hedges | Maximum
Derivative [Line Items]
Exchange rates | € / £	1.1914	1.1750	1.1750
Euros | Purchase hedges
Derivative [Line Items]
Contract totals/£m | £	£ 0.8	£ 0.8
Exchange rates | € / £		1.1663	1.1663
Euros | Purchase hedges | Minimum
Derivative [Line Items]
Exchange rates | € / £	1.1663
Canadian dollars | Purchase hedges
Derivative [Line Items]
Contract totals/£m | £	£ 6.8	£ 7.0
Canadian dollars | Purchase hedges | Minimum
Derivative [Line Items]
Exchange rates	1.7018	1.7137	1.7137
Canadian dollars | Purchase hedges | Maximum
Derivative [Line Items]
Exchange rates	1.7240	1.7664	1.7664
Japan, Yen | Sales hedges
Derivative [Line Items]
Contract totals/£m | ¥			¥ 0.1
Exchange rates | ¥ / £		142.8600	142.8600

XML

Goodwill and other identifiable intangible assets - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Mar. 29, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets
Gross	$ 21.0	$ 21.5
Accumulated amortization	(8.0)	(7.9)
Net	13.0	13.6
Customer relationships
Finite-Lived Intangible Assets
Gross	13.4	13.4
Accumulated amortization	(4.8)	(4.6)
Net	8.6	8.8
Technology and trading related
Finite-Lived Intangible Assets
Gross	7.6	8.1
Accumulated amortization	(3.2)	(3.3)
Net	$ 4.4	$ 4.8

XML

Debt - Schedule of Debt Outstanding (Details) - USD ($) $ in Millions	Mar. 29, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Long-term debt, gross	$ 109.7
Unamortized debt issuance costs	(0.9)	$ (1.1)
Total debt	108.8	91.4
Less current portion	0.0	0.0
Long-term debt	108.8	91.4
Loan Notes | Loan Notes due 2021
Debt Instrument [Line Items]
Long-term debt, gross	$ 25.0	25.0
Debt stated interest rate	3.67%
Loan Notes | Loan Notes due 2023
Debt Instrument [Line Items]
Long-term debt, gross	$ 25.0	25.0
Debt stated interest rate	4.88%
Loan Notes | Loan Notes due 2026
Debt Instrument [Line Items]
Long-term debt, gross	$ 25.0	25.0
Debt stated interest rate	4.94%
Revolving credit facility
Debt Instrument [Line Items]
Long-term debt, gross	$ 34.7	$ 17.5

XML

Segmental Information - Reconciliation of consolidated segment income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Segment Reporting [Abstract]
Adjusted EBITDA	$ 15.1	$ 18.5
Other share-based compensation charges	(0.5)	(2.6)
Depreciation and amortization	(3.6)	(3.7)
Restructuring charges	(2.8)	(9.0)
Impairment charges	0.0	0.2
Acquisition related costs	(0.2)	(4.6)
Defined benefits pension pension credit	1.1	0.6
Interest expense, net	(1.2)	(1.1)
Provision for income taxes	(1.7)	(2.1)
Net income / (loss)	$ 6.2	$ (3.8)

XML

Revenue

3 Months Ended

Mar. 29, 2020

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

Disaggregated sales disclosures for the quarter ended March 29, 2020, and March 31, 2019, are included below and in Note 14, Segmental Information.

	First Quarter
	2020						2019
In millions	Gas Cylinders		Elektron		Total		Gas Cylinders		Elektron		Total
General industrial	$	11.9	$	27.7	$	39.6	$	13.1	$	30.6	$	43.7
Transportation	18.9		11.2		30.1		20.9		19.1		40.0
Defense and emergency	18.1		11.4		29.5		18.7		10.5		29.2
Healthcare	3.7		0.9		4.6		5.7		1.8		7.5
	$	52.6	$	51.2	$	103.8	$	58.4	$	62.0	$	120.4

The Company’s performance obligations are satisfied over time as work progresses or at a point in time. Design and tooling arrangements are the only contracts for which sales are recognized over time. Sales from these sources combined accounted for less than 1% of the Company’s sales for the quarters ended March 29, 2020, and March 31, 2019. All consideration from contracts with customers is included in these amounts.

The following table provides information about contract receivables, contract assets and contract liabilities from contracts with customers:

In millions	March 29, 2020			December 31, 2019
Contract receivables	$	1.5		$	1.7
Contract assets	0.5			1.3
Contract liabilities	(0.4		)	(0.5		)

Contract assets consist of $0.5 million accrued unbilled amounts relating to tooling revenue and are recognized in prepayments and accrued income in the consolidated balance sheets. Of the $1.3 million contract assets recognized as of December 31, 2019, $0.4 million was billed to customers and transferred to receivables as of March 29, 2020.

Contract liabilities of $0.4 million consist of advance payments and billing above costs incurred and are recognized as other current liabilities. Significant changes in contract liabilities balances during the period are as follows:

In millions	2020
As at January 1,	$	(0.5	)
Net (payments received) / amounts billed	(0.1		)
Net (costs incurred) / revenue recognized	0.2
As at March 29,	$	(0.4	)

XML

Supplementary balance sheet information

3 Months Ended

Mar. 29, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplementary balance sheet information

Supplementary balance sheet information

	March 29,			December 31,
In millions	2020			2019
Accounts and other receivables
Trade receivables	$	62.2		$	52.4
Related parties	2.6			2.7
Prepayments and accrued income	4.9			6.7
Derivative financial instruments	0.4			0.3
Other receivables	3.5			4.2
Total accounts and other receivables	$	73.6		$	66.3
Inventories
Raw materials and supplies	$	34.0		$	33.4
Work-in-process	33.7			32.2
Finished goods	26.2			28.9
Total inventories	$	93.9		$	94.5
Other current assets
Held-for-sale assets	$	3.8		$	3.9
Income tax receivable	0.3			1.1
Total other current assets	$	4.1		$	5.0
Property, plant and equipment, net
Land, buildings and leasehold improvements	$	68.4		$	68.1
Machinery and equipment	278.2			287.7
Construction in progress	7.0			8.9
Total property, plant and equipment	353.6			364.7
Accumulated depreciation and impairment	(259.3		)	(265.8		)
Total property, plant and equipment, net	$	94.3		$	98.9
Other current liabilities
Contingent liabilities	$	7.0		$	6.6
Derivative financial instruments	0.6			—
Operating lease liability	3.1			3.3
Other current liabilities	1.5			2.4
Total other current liabilities	$	12.2		$	12.3
Other non-current liabilities
Contingent liabilities	$	0.9		$	0.9
Operating lease liability	10.6			11.7
Other non-current liabilities	0.2			0.2
Total other non-current liabilities	$	11.7		$	12.8

6.    Supplementary balance sheet information (continued)

Held-for-sale assets and liabilities

Held-for-sale assets	March 29,		December 31,
In millions	2020		2019
Property, plant and equipment	$	3.7	$	3.7
Inventory	0.1		0.2
Held-for-sale assets	$	3.8	$	3.9

During 2018, a building within our Elektron Segment was classified as held-for-sale assets, presented within other current assets. The building was part of a site closure announced in 2017 and were readily available for sale at December 31, 2018. The site at Riverhead, NY is now expected to be sold during 2020 and is included within held-for-sale assets as at March 29, 2020 and December 31, 2019.

XML

Basis of Presentation and Responsibility for interim Financial Statements (Details) $ in Millions	Mar. 29, 2020 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Allowance for credit losses	$ 1.9

XML

Pension Plans (Tables)

3 Months Ended

Mar. 29, 2020

Retirement Benefits [Abstract]

Schedule of Net Benefit Costs

Components of net periodic benefit cost for our pension plans for the First Quarter ended March 29, 2020, and March 31, 2019 were as follows:

	First Quarter
In millions	2020			2019
Net periodic benefit credit
Interest cost	$	2.3		$	2.7
Expected return on plan assets	(3.6		)	(3.8		)
Amortization of:
Net actuarial loss	0.5			0.7
Prior service credit	(0.1		)	(0.1		)
Net periodic benefit credit	$	(0.9	)	$	(0.5	)
In respect of defined contribution plans
Total charge for defined contribution plans	1.1			1.2
Total charge for pension plans	$	0.2		$	0.7

XML

Goodwill and other identifiable intangible assets (Tables)

3 Months Ended

Mar. 29, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

Changes in goodwill during the First Quarter, ended March 29, 2020, were as follows:

In millions	Gas Cylinders			Elektron			Total
At January 1, 2020	$	27.0		$	41.8		$	68.8
Exchange difference	(1.6		)	(1.0		)	(2.6		)
Balance at March 29, 2020	$	25.4		$	40.8		$	66.2

Schedule of Intangible Assets

Identifiable intangible assets consisted of the following:

	March 29, 2020							December 31, 2019
In millions	Gross		Accumulated amortization			Net		Gross		Accumulated amortization			Net
Customer relationships	$	13.4	$	(4.8	)	$	8.6	$	13.4	$	(4.6	)	$	8.8
Technology and trading related	7.6		(3.2		)	4.4		8.1		(3.3		)	4.8
	$	21.0	$	(8.0	)	$	13.0	$	21.5	$	(7.9	)	$	13.6

XML

Goodwill and other identifiable intangible assets - Schedule of Goodwill (Details) $ in Millions	3 Months Ended
	Mar. 29, 2020 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 68.8
Exchange difference	(2.6)
Ending balance	66.2
Gas Cylinders
Goodwill [Roll Forward]
Beginning balance	27.0
Exchange difference	(1.6)
Ending balance	25.4
Elektron
Goodwill [Roll Forward]
Beginning balance	41.8
Exchange difference	(1.0)
Ending balance	$ 40.8

XML

Supplementary balance sheet information - Schedule of Current Held-for-Sale Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 29, 2020	Dec. 31, 2019
Held-for-sale assets
Held-for-sale assets	$ 3.8	$ 3.9
Held-for-sale
Held-for-sale assets
Property, plant and equipment	3.7	3.7
Inventory	0.1	0.2
Held-for-sale assets	$ 3.8	$ 3.9

XML

Derivatives and Financial Instruments - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 29, 2020	Dec. 31, 2019
Derivative [Line Items]
Derivative loss deferred in equity	$ 0
Derivative (loss) gain transferred to consolidated income statement	0
Long-term debt outstanding	108,800,000	$ 91,400,000
Debt issuance costs	900,000	1,100,000
Variable interest rate debt	34,700,000	17,500,000
Accounts and Other Receivables
Derivative [Line Items]
Derivative financial assets	400,000	300,000
Other Current Liabilities
Derivative [Line Items]
Derivative financial liabilities	200,000	100,000
Bank and other loans
Derivative [Line Items]
Long-term debt outstanding	$ 109,700,000	$ 92,500,000

XML

Commitments and Contingencies - Additional Information (Details) £ in Millions	1 Months Ended	3 Months Ended			12 Months Ended
	Feb. 28, 2014 people	Mar. 29, 2020 USD ($) facility	Mar. 29, 2020 GBP (£) facility	Mar. 31, 2019 USD ($)	Dec. 31, 2019 USD ($) facility	Mar. 29, 2020 GBP (£)	Dec. 31, 2019 GBP (£)
Loss Contingencies [Line Items]
Amount drawn/utilized				$ 17,200,000
Number of bonding facilities for bank guarantees | facility		2	2
Borrowing capacity		$ 4,000,000.0			$ 0
Credit facility, amount drawn		0
Individuals With minor injuries | people	3
Committed Banking Facilities
Loss Contingencies [Line Items]
Debt maximum borrowing capacity		150,000,000.0			150,000,000.0
Other - Bank overdraft
Loss Contingencies [Line Items]
Amount drawn/utilized		34,700,000			17,500,000
Bonding Facility For Bank Guarantees
Loss Contingencies [Line Items]
Debt maximum borrowing capacity		5,500,000			5,900,000	£ 4.5
Amount drawn/utilized		1,900,000	£ 1.6		2,300,000
Letter of Credit
Loss Contingencies [Line Items]
Debt maximum borrowing capacity		1,200,000			1,300,000	£ 1.0	£ 1.0
Amount drawn/utilized		$ 0			$ 0
United Kingdom, Pounds
Loss Contingencies [Line Items]
Number of bonding facilities for bank guarantees | facility					1
U.S. dollars
Loss Contingencies [Line Items]
Number of bonding facilities for bank guarantees | facility		1	1
U.S. dollars | Bonding Facility For Bank Guarantees
Loss Contingencies [Line Items]
Amount drawn/utilized		$ 400,000			$ 400,000

XML

Acquisition related costs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Business Combinations [Abstract]
Acquisition related costs	$ (0.2)	$ (4.6)
Release of deferred consideration (recognized in acquisition-related costs)	$ 0.1
Acquisition-related costs		4.6
Acquisition termination payment		$ 3.5

XML

Revenue - Significant Changes in Contract Liabilities (Details) $ in Millions	3 Months Ended
	Mar. 29, 2020 USD ($)
Contract With Customer, Asset (Liability) [Roll Forward]
Beginning balance	$ (0.5)
Net (payments received) / amounts billed	(0.1)
Net (costs incurred) / revenue recognized	0.2
Ending balance	$ (0.4)

XML

Earnings per share (Details) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 29, 2020 USD ($) $ / shares shares	Mar. 31, 2019 USD ($) $ / shares shares	Mar. 29, 2020 £ / shares	Dec. 31, 2019 £ / shares	Mar. 31, 2019 £ / shares
Basic earnings:
Net income / (loss) | $	$ 6.2	$ (3.8)
Weighted average number of £0.50 ordinary shares:
For basic earnings per share (shares)	27,440,423	27,032,677
Dilutive effect of potential common stock (shares)	453,635	0
For diluted earnings per share (shares)	27,894,058	27,032,677
Earnings / (loss) per share using weighted average number of ordinary shares outstanding:
Basic earnings per ordinary share (usd per share) | $ / shares	$ 0.23	$ (0.14)
Diluted earnings per ordinary share (usd per share) | $ / shares	$ 0.22	$ (0.14)
Class of Stock [Line Items]
Shares not included in the computation of diluted EPS (in shares)	735,730
Ordinary shares
Class of Stock [Line Items]
Common stock, par value (in GBP per share) | £ / shares			£ 0.50	£ 0.50	£ 0.50

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) / INCOME (UNAUDITED) CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) / INCOME (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Pension and post-retirement actuarial gains / (losses), tax	$ 0.1	$ 0.1
Cash flow hedges, tax	$ 0.0	$ 0.0

XML

Income Taxes - Additional Information (Details)	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Effective income tax rate	(21.50%)	131.30%

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($) shares in Millions, $ in Millions	Total	Additional paid-in capital	Treasury shares	Own shares held by ESOP	Retained earnings	Accumulated other comprehensive loss	Ordinary shares Common stock	[1]	Deferred shares Common stock	[2]
Beginning balance at Dec. 31, 2018	$ 184.3	$ 65.6	$ (4.3)	$ (2.2)	$ 95.3	$ (146.6)	$ 26.6		$ 149.9
Beginning balance (in shares) at Dec. 31, 2018			(0.4)	(1.6)
Net income / (loss)	(3.8)				(3.8)
Shares sold from ESOP	1.4	1.3		$ 0.1
Shares sold from ESOP (in shares)				0.1
Other comprehensive (loss) income, net of tax	2.1					2.1
Dividends declared	(3.4)				(3.4)
Share-based compensation	(0.8)	(0.8)
Utilization of treasury shares to satisfy share based compensation				0.1
Utilization of treasury shares to satisfy share based compensation	0.0	(0.2)		$ 0.2	0.0
Ending balance at Mar. 31, 2019	179.8	65.9	$ (4.3)	$ (1.9)	88.1	(144.5)	26.6		149.9
Ending balance (in shares) at Mar. 31, 2019			(0.5)	(1.4)
Beginning balance at Dec. 31, 2019	174.4	68.4	$ (4.0)	$ (1.7)	84.8	(149.6)	26.6		149.9
Beginning balance (in shares) at Dec. 31, 2019			(0.4)	(1.2)
Net income / (loss)	6.2				6.2
Other comprehensive (loss) income, net of tax	(7.3)					(7.3)
Dividends declared	(3.4)				(3.4)
Share-based compensation	0.5	0.5
Utilization of shares from ESOP to satisfy share based compensation	(0.6)	(0.7)		$ 0.1
Utilization of shares from ESOP to satisfy share based compensation (in shares)				0.1
Ending balance at Mar. 29, 2020	$ 169.8	$ 68.2	$ (4.0)	$ (1.6)	$ 87.6	$ (156.9)	$ 26.6		$ 149.9
Ending balance (in shares) at Mar. 29, 2020			(0.4)	(1.1)

[1]
Ordinary share capital includes 29,000,000 shares in 2020, 29,000,000 shares in 2019, respectively.

[2] Deferred share capital includes 761,835,338,444 shares in 2020, and 761,835,338,444 shares in 2019.

XML

Share Plans - Additional Information (Details) shares in Thousands	3 Months Ended
	Mar. 29, 2020 $ / shares shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Granted during the year (in shares) | shares	130
Granted during the year (in USD per share) | $ / shares	$ 11.30

XML

Pension Plans

3 Months Ended

Mar. 29, 2020

Retirement Benefits [Abstract]

Pension Plans

Pension Plans

The principal defined benefit pension plan in the U.K. is the Luxfer Group Pension Plan. The Company’s other arrangements are less significant than the Luxfer Group Pension Plan, the largest being the BA Holdings, Inc. Pension Plan in the U.S.

Components of net periodic benefit cost for our pension plans for the First Quarter ended March 29, 2020, and March 31, 2019 were as follows:

	First Quarter
In millions	2020			2019
Net periodic benefit credit
Interest cost	$	2.3		$	2.7
Expected return on plan assets	(3.6		)	(3.8		)
Amortization of:
Net actuarial loss	0.5			0.7
Prior service credit	(0.1		)	(0.1		)
Net periodic benefit credit	$	(0.9	)	$	(0.5	)
In respect of defined contribution plans
Total charge for defined contribution plans	1.1			1.2
Total charge for pension plans	$	0.2		$	0.7

In accordance with ASC 715, defined benefit credit is split in the income statement, with $0.2 million (2019: $0.1 million) of expenses recognized within Selling, general and administrative expenses and a credit of $1.1 million (2019: $0.6 million) recognized below Operating income / (loss) in the income statement.

XML

Commitments and Contingencies

3 Months Ended

Mar. 29, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Committed and uncommited banking facilities

At March 29, 2020, and December 31, 2019, the Company had committed banking facilities of $150.0 million. The facilities were for providing loans, with a with a separate facility for letters of credit which at March 29, 2020, was £1.0 million ($1.2 million) and December 31, 2019, was £1.0 million ($1.3 million). Of the committed facilities, $34.7 million was drawn for loans and no letters of credit were utilized at March 29, 2020, $17.5 million, and nil at December 31, 2019. The Company also has two separate bonding facilities for bank guarantees, one denominated in GBP sterling of £4.5 million (2020: $5.5 million, 2019: $5.9 million), of which £1.6 million (2020: $1.9 million, 2019: $2.3 million) was utilized at March 29, 2020, and December 31, 2019, respectively and one denominated in USD of $0.4 million which was fully utilized at March 29, 2020 and December 31, 2019 respectively. The Company also has a $4.0 million separate overdraft facility of which none was drawn at March 29, 2020, nil and nil at December 31, 2019.

Contingencies

During February 2014, a cylinder was sold to a long-term customer and ruptured at one of their gas facilities. As a result of this rupture, three people were noted to have minor injuries such as loss of hearing. There was no major damage to assets of the customer. A claim was launched by the three people who were injured in the incident. We have reviewed our quality control checks from around the time which the cylinder was produced and no instances of failures have been noted. It has also been noted by the investigator that the customer has poor quality and safety checks. As a result, we do not believe that we are liable for the incident, and therefore, do not currently expect this case to have a material impact on the Company's financial position or results of operations.

XML

Earnings per share (Tables)

3 Months Ended

Mar. 29, 2020

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

Basic and diluted earnings per share were calculated as follows:

	First Quarter
In millions except share and per-share data	2020		2019
Basic earnings:
Net income / (loss)	$	6.2	$	(3.8	)
Weighted average number of £0.50 ordinary shares:
For basic earnings per share	27,440,423		27,032,677
Dilutive effect of potential common stock	453,635		—
For diluted earnings per share	27,894,058		27,032,677
Earnings / (loss) per share using weighted average number of ordinary shares outstanding:
Basic earnings / (loss) per ordinary share	$	0.23	$	(0.14	)
Diluted earnings / (loss) per ordinary share	$	0.22	$	(0.14	)

XML

Shareholders' Equity (Tables)

3 Months Ended

Mar. 29, 2020

Equity [Abstract]

Schedule of Dividends Paid and Proposed

In millions	2020		2019
Dividends declared and paid during the year:
Interim dividend paid February 6, 2019 ($0.125 per ordinary share)	$	—	$	3.4
Interim dividend paid February 5, 2020 ($0.125 per ordinary share)	3.4		—
	$	3.4	$	3.4

In millions	2020		2019
Dividends declared and paid after the quarter end (not recognized as a liability at the quarter end):
Interim dividend declared April 1, and paid May 1, 2019: ($0.125 per ordinary share)	$	—	$	3.4
Interim dividend declared April 6, and to be paid May 6, 2020: ($0.125 per ordinary share)	3.4		—
	$	3.4	$	3.4

XML

Debt (Tables)

3 Months Ended

Mar. 29, 2020

Debt Disclosure [Abstract]

Schedule of Debt

Debt outstanding was as follows:

In millions	March 29, 2020			December 31, 2019
3.67% Loan Notes due 2021	$	25.0		$	25.0
4.88% Loan Notes due 2023	25.0			25.0
4.94% Loan Notes due 2026	25.0			25.0
Revolving credit facility	34.7			17.5
Unamortized debt issuance costs	(0.9		)	(1.1		)
Total debt	$	108.8		$	91.4
Less current portion	$	—		$	—
Non-current debt	$	108.8		$	91.4

Schedule of Maturities of Company's Debt

The maturity profile of the Company's debt, excluding unamortized issuance costs and discounts, is as follows:

In millions	2020		2021		2022		2023		2024		2025		Thereafter		Total
Loan Notes due 2021	$	—	$	25.0	$	—	$	—	$	—	$	—	$	—	$	25.0
Loan Notes due 2023	—		—		—		25.0		—		—		—		25.0
Loan Notes due 2026	—		—		—		—		—		—		25.0		25.0
Revolving credit facility	—		—		34.7		—		—		—		—		34.7
Total debt	$	—	$	25.0	$	34.7	$	25.0	$	—	$	—	$	25.0	$	109.7

XML

Derivatives and Financial Instruments

3 Months Ended

Mar. 29, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives and Financial Instruments

Derivatives and Financial Instruments

The Company's financial instruments comprise bank and other loans, senior loan notes, derivatives, trade payables deferred and deferred contingent consideration. Other than derivatives, the main purpose of these financial instruments is to raise finance for the Company's operations. The Company also has various financial assets such as trade receivables and cash and cash equivalents, which arise directly from its operations.

Derivative financial instruments                                        We are exposed to market risk during the normal course of business from changes in currency exchange rates, interest rates and commodity prices such as aluminum prices. We manage exposures through a combination of normal operating and financing activities and through the use of derivative financial instruments such as foreign currency forward purchase contracts and aluminum forward purchase contracts. We do not use market risk-sensitive instruments for trading or speculative purposes. The Company had $0.4 million and $0.3 million derivative financial instruments disclosed within Accounts and other receivables as of March 29, 2020 and December 31, 2019, respectively. There were also $0.2 million and less than $0.1 million derivative financial instruments recorded in Other current liabilities at March 29, 2020, and December 31, 2019, respectively.

The fair value of forward foreign currency exchange contracts deferred in equity was nil at March 29, 2020, and December 31, 2019, respectively. During the First Quarter of 2020, nothing was transferred to the Income Statement.

Forward foreign currency exchange contracts                                    The Company incurs currency transaction risk whenever one of the Company's operating subsidiaries enters into either a purchase or sales transaction in a currency other than its functional currency. Currency transaction risk is reduced by matching sales and expenses in the same currency. The Company's U.S. operations have little currency exposure, as most purchases, costs and sales are conducted in U.S. dollars. The Company's U.K. operations are exposed to exchange transaction risks, mainly because these operations sell goods priced in euros and U.S. dollars, and purchase raw materials priced in U.S. dollars and its functional currency is GBP sterling. The Company also incurs currency transaction risk if it lends currency other than its functional currency to one of its joint venture partners.

At March 29, 2020, and December 31, 2019, the Company held various forward foreign currency exchange contracts designated as hedges in respect of forward sales for U.S. dollars, euros and Japanese Yen for the receipt of GBP sterling or euros. The Company also held forward foreign currency exchange contracts designated as hedges in respect of forward purchases for U.S. dollars, euros and Canadian dollars by the sale of GBP sterling. The contract totals in GBP sterling, range of maturity dates and range of exchange rates are disclosed below, with the value denominated in GBP sterling given that is the currency the majority of the contracts are held in.

	March 29, 2020
Sales hedges	U.S. dollars	Euros
Contract totals/£m	6.8	9.9
Maturity dates	04/20	04/20 to 06/20
Exchange rates	$1.1617 to $1.2281	€1.1151 to €1.1914

Purchase hedges	U.S. dollars	Euros	Canadian dollars
Contract totals/£m	1.4	0.8	6.8
Maturity dates	04/20 to 06/20	03/20	03/20 to 04/20
Exchange rates	$1.2303 to $1.3132	€1.1663	$1.7018 to $1.7240

	December 31, 2019
Sales hedges	U.S. dollars	Euros	Japanese Yen
Contract totals/£m	0.1	7.6	0.1
Maturity dates	01/20	01/20 to 03/20	01/20
Exchange rates	$1.2914	€1.1551 to €1.1750	JPY 142.86

Purchase hedges	U.S. dollars	Euros	Canadian dollars
Contract totals/£m	1.3	0.8	7.0
Maturity dates	03/20	03/20	01/20
Exchange rates	$1.3228	€1.1663	$1.7137 to $1.7664

The above contracts are held in GBP sterling, therefore the analysis in the table has been given in GBP sterling to avoid any movements as a result of translation.

9.    Derivatives and Financial Instruments (continued)

Fair value of financial instruments                                        

The following methods were used to estimate the fair values of each class of financial instrument:

Cash at bank and in hand / overdrafts                                        The carrying value approximates to the fair value as a result of the short-term maturity of the instruments. Cash at bank and in hand are subject to a right to offset in the U.S.

Bank loans                                                    Bank and other loans, excluding overdrafts, of $109.7 million were outstanding at March 29, 2020, and $92.5 million were outstanding at December 31, 2019. Bank and other loans are shown net of issue costs of $0.9 million and $1.1 million at March 29, 2020, and December 31, 2019, respectively, and are to be amortized to the expected maturity of the facilities. Of the bank and other loans outstanding, $34.7 million and $17.5 million is variable interest rate debt and subject to floating interest rate risk, with the remainder being fixed rate debt, at March 29, 2020, and December 31, 2019, respectively.

Forward foreign currency exchange rate contracts                                The fair value of these contracts was calculated by determining what the Company would be expected to receive or pay on termination of each individual contract by comparison to present market prices.

LME derivative contracts                                            The fair value of these contracts has been calculated by valuing the contracts against the equivalent forward rates quoted on the LME.

Deferred contingent consideration                                    

The deferred contingent consideration was in relation to the acquisition of Truetech and Innotech (Luxfer Magtech) in 2014 and was linked to the future profitability of the entity. All consideration in relation to this acquisition has now been paid as at March 29, 2020.

Fair value hierarchy

The Company uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

The fair values of the financial instruments of the Company at March 29, 2020, were analyzed using the hierarchy as follows:

In millions	Total		Level 1		Level 2		Level 3
Derivative financial assets:
Foreign currency contract assets	$	0.4	$	—	$	0.4	$	—
Derivative financial liabilities:
Foreign currency contract liabilities	0.6		—		0.6		—
Interest bearing loans and borrowings:
Loan Notes due 2021	25.0		—		25.0		—
Loan Notes due 2023	25.4		—		25.4		—
Loan Notes due 2026	26.1		—		26.1		—
Revolving Credit Facility	34.7		—		34.7		—

9.    Derivatives and Financial Instruments (continued)

The following table presents the changes in Level 3 instruments for the First Quarter ended March 29, 2020.

In millions	2020
Balance at January 1,	$	0.5
Payments made during year	(0.4		)
Release of deferred consideration (recognized in acquisition-related costs)	(0.1		)
Balance at March 29,	$	—
Total credit for the period included in profit and loss for assets held at the end at March 29	(0.1		)
Change in unrealized (gains) or losses for the period included in profit and loss for assets held at the end at March 29,	$	(0.1	)

XML

Basis of Presentation and Responsibility for interim Financial Statements

3 Months Ended

Mar. 29, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Responsibility for interim Financial Statements

Basis of Presentation and Responsibility for interim Financial Statements

We prepared the accompanying unaudited consolidated condensed financial statements of Luxfer Holdings PLC and all wholly-owned, majority owned or otherwise controlled subsidiaries on the same basis as our annual audited financial statements, except for the adoption for Accounting Standards Update ("ASU") 2016-13, "current expected credit loss model". We condensed or omitted certain information and footnote disclosures normally included in our annual audited financial statements, which we prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP).

Our quarterly financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2019. As used in this report, the terms "we," "us," "our," "Luxfer" and "the Company" mean Luxfer Holdings PLC and its subsidiaries, unless the context indicates another meaning.

In the opinion of management, our financial statements reflect all adjustments, which are of a normal recurring nature, necessary for presentation of financial statements for interim periods in accordance with U.S. GAAP and with the instructions to Form 10-Q in Article 10 of Securities and Exchange Commission (SEC) Regulation S-X.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of our financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and any such differences may be material to our financial statements.

Our fiscal year ends on December 31. We report our interim quarterly periods on a 13-week quarter basis, ending on a Sunday. The First Quarter, 2020, ended March 29, 2020, and the First Quarter, 2019, ended March 31, 2019.

Impact of COVID-19 on the Financial Statements

In March 2020, the World Health Organization characterized the coronavirus ("COVID-19") a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the pandemic and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment, unprecedented market volatility and heightened degree of uncertainty resulting from COVID-19, we are currently unable to fully determine its future impact on our business. However, we are monitoring the progression of the pandemic and its potential effect on our financial position, results of operations and cash flows.

The Company recognizes that the COVID-19 pandemic constitutes a triggering event in accordance with ASC 350 Intangibles - Goodwill and Other, and has therefore performed an impairment assessment of its goodwill and other intangible assets. Based on current forecast information we did not identify any impairments, nor marginal outcomes. Assumptions and judgments are required in calculating the fair value of the reporting units. In developing our discounted cash flow analysis, assumptions about future revenues and expenses, capital expenditures and changes in working capital are based on our annual operating plan and long-term business plan for each of our reporting units. These plans take into consideration numerous factors including historical experience, anticipated future economic conditions, changes in raw material prices and growth expectations for the industries and end markets we participate in. These assumptions and judgments may change as we learn more about the impact of the COVID-19 pandemic

In relation to liquidity, the Company has access to a large revolving credit facility and has performed stress testing on financial covenants using current forecast information and has not identified any liquidity concerns.

Adoption of new accounting standards

Current expected credit loss ("CECL") model

On January 1, 2020, the Company adopted ASU 2016-13, financial instruments - Credit Losses (Topic 326): Measurement of credit losses on Financial Instruments prospectively. The ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including trade receivables.

• Under the CECL model, the Company is required to consider whether expected credit losses should be recognized for trade receivables that are considered “current” (i.e., not past due).

• When using historical loss rates in a provision matrix, the Company is required to consider whether and, if so, how the historical loss rates differ from what is currently expected over the life of the trade receivables (on the basis of current conditions and reasonable and supportable forecasts about the future).

Upon adoption, there was no adjustment made to opening retained earnings as at January 1, 2020.

As a result of implementing ASU 2016-13, the Company did not recognize any material additional allowance within Accounts and Other Receivables as at January 1, 2020. Accounts and Other Receivables are shown net of a $1.9 million allowance at March 29, 2020.

The Company is exposed to credit losses primarily through sales of products. The Company’s expected loss allowance methodology for accounts receivable is developed using historical collection experience, current and future economic and market conditions and a review of the current status of customers' trade accounts receivables. Due to the short-term nature of such receivables, the estimate of accounts receivable amounts that may not be collected is based on aging of the accounts receivable balances and the financial condition of customers. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. The Company considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic and determined that the estimate of credit losses was not significantly impacted.

Estimates are used to determine the allowance. It is based on assessment of anticipated receipts and all other historical, current and future information that is reasonably available.

The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected.

In millions	2020
Balance at January 1,	$	1.3
Adoption of ASU 2016-13, cumulative-effect adjustment to retained earnings	—
Provisions for expected credit losses	0.7
Other, including foreign currency translation	(0.1		)
Balance at March 29,	$	1.9

Accounting standards issued but not yet effective

None that will be material to the Company.

XML

Acquisition related costs

3 Months Ended

Mar. 29, 2020

Business Combinations [Abstract]

Acquisition related costs

Acquisition related costs

Acquisition-related costs of $0.2 million in 2020 represents amounts incurred in relation to M&A exploration activities net of a $0.1 million release of deferred contingent consideration.

Acquisition-related costs of $4.6 million in the First Quarter, 2019 related to a $3.5 million termination payment and our professional and legal fees incurred in connection with the aborted acquisition of Neo Performance Materials.

XML

Segmental Information - Geographic information by region (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 94.3		$ 98.9
Net sales	103.8	$ 120.4
Top five countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	79.7	92.8
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	56.0		57.3
Net sales	59.7	61.4
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	33.7		36.7
Net sales	7.4	11.5
Germany
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3.6	8.2
Italy
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	4.4	6.5
France
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	4.6	5.2
Rest of Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	1.0		1.0
Net sales	7.1	11.8
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	0.3		0.3
Net sales	11.5	11.6
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	3.3		$ 3.6
Net sales	$ 5.5	$ 4.2
Geographic Concentration Risk | Revenue from Contract with Customer | Top five countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	76.80%	77.10%
Geographic Concentration Risk | Revenue from Contract with Customer | United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	57.50%	51.00%
Geographic Concentration Risk | Revenue from Contract with Customer | United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	7.10%	9.60%
Geographic Concentration Risk | Revenue from Contract with Customer | Germany
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	3.50%	6.80%
Geographic Concentration Risk | Revenue from Contract with Customer | Italy
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	4.20%	5.40%
Geographic Concentration Risk | Revenue from Contract with Customer | France
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	4.40%	4.30%
Geographic Concentration Risk | Revenue from Contract with Customer | Rest of Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	6.80%	9.80%
Geographic Concentration Risk | Revenue from Contract with Customer | Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	11.10%	9.60%
Geographic Concentration Risk | Revenue from Contract with Customer | Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	5.30%	3.50%

XML

Goodwill and other identifiable intangible assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 0.2	$ 0.3
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity
2020	0.5
2021	0.7
2022	0.7
2023	0.7
2024	0.7
2025	$ 0.7

XML

Debt - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 29, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Amount drew down during the period, on line of credit	$ 17,200,000
Long-term debt, gross		$ 109,700,000
Borrowing capacity		$ 4,000,000.0	$ 0
Revolving credit facility
Debt Instrument [Line Items]
Debt, weighted average interest rate		2.32%	2.47%
Long-term debt, gross		$ 34,700,000	$ 17,500,000
Borrowing capacity		$ 115,300,000	$ 132,500,000

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) $ in Millions	Mar. 29, 2020 USD ($) shares	Mar. 29, 2020 £ / shares	Dec. 31, 2019 USD ($) shares	Dec. 31, 2019 £ / shares
Statement of Financial Position [Abstract]
Accounts and other receivables, allowances | $	$ 1.9		$ 1.3
Ordinary shares
Common stock, par value (in GBP per share) | £ / shares		£ 0.50		£ 0.50
Common stock, shares authorized (in shares)	40,000,000		40,000,000
Common stock, shares issued (in shares)	29,000,000		29,000,000
Common stock, shares outstanding (in shares)	29,000,000		29,000,000
Deferred shares
Common stock, par value (in GBP per share) | £ / shares		£ 0.0001		£ 0.0001
Common stock, shares authorized (in shares)	761,845,318,444		761,845,318,444
Common stock, shares issued (in shares)	761,835,338,444		761,835,338,444
Common stock, shares outstanding (in shares)	761,835,338,444		761,835,338,444

XML

Shareholders' Equity - Schedule of Dividend Paid and Proposed (Details) - USD ($) $ / shares in Units, $ in Millions					3 Months Ended
	May 06, 2020	Feb. 05, 2020	May 01, 2019	Feb. 06, 2019	Mar. 29, 2020	Mar. 31, 2019
Class of Stock [Line Items]
Dividends paid		$ 3.4	$ 3.4	$ 3.4	$ 3.4	$ 3.4
Dividends paid (in USD per share)		$ 0.125	$ 0.125	$ 0.125
Subsequent Event
Class of Stock [Line Items]
Dividends paid	$ 3.4
Dividends paid (in USD per share)	$ 0.125

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net sales	$ 103.8	$ 120.4
Cost of goods sold	(79.3)	(90.3)
Gross profit	24.5	30.1
Selling, general and administrative expenses	(12.8)	(16.4)
Research and development	(0.7)	(1.4)
Restructuring charges	(2.8)	(9.0)
Impairment charges	0.0	0.2
Acquisition related costs	(0.2)	(4.6)
Operating income / (loss)	8.0	(1.1)
Interest expense	(1.2)	(1.1)
Defined benefit pension credit	1.1	0.6
Income / (loss) before income taxes and equity in net income of affiliates	7.9	(1.6)
Provision for income taxes	(1.7)	(2.1)
Income / (loss) before equity in net income of affiliates	6.2	(3.7)
Equity income / (loss) of affiliates (net of tax)	0.0	(0.1)
Net income / (loss)	$ 6.2	$ (3.8)
Earnings / (loss) per share
Basic (usd per share)	$ 0.23	$ (0.14)
Diluted (usd per share)	$ 0.22	$ (0.14)
Weighted average ordinary shares outstanding
Basic (shares)	27,440,423	27,032,677
Diluted (shares)	27,894,058	27,032,677

XML

Derivatives and Financial Instruments - Fair Values of Financial Instruments (Details) $ in Millions	Mar. 29, 2020 USD ($)
Foreign currency contract
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency contract assets	$ 0.4
Foreign currency contract liabilities	0.6
Foreign currency contract | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency contract assets	0.0
Foreign currency contract liabilities	0.0
Foreign currency contract | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency contract assets	0.4
Foreign currency contract liabilities	0.6
Foreign currency contract | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency contract assets	0.0
Foreign currency contract liabilities	0.0
Loan Notes | Loan Notes due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	25.0
Loan Notes | Loan Notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	25.4
Loan Notes | Loan Notes due 2026
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	26.1
Loan Notes | Level 1 | Loan Notes due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	0.0
Loan Notes | Level 1 | Loan Notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	0.0
Loan Notes | Level 1 | Loan Notes due 2026
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	0.0
Loan Notes | Level 2 | Loan Notes due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	25.0
Loan Notes | Level 2 | Loan Notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	25.4
Loan Notes | Level 2 | Loan Notes due 2026
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	26.1
Loan Notes | Level 3 | Loan Notes due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	0.0
Loan Notes | Level 3 | Loan Notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	0.0
Loan Notes | Level 3 | Loan Notes due 2026
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	0.0
Revolving credit facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	34.7
Revolving credit facility | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	0.0
Revolving credit facility | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	34.7
Revolving credit facility | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest bearing loans and borrowings	$ 0.0

XML

Pension plans - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Defined benefit pension credit	$ 0.9	$ 0.5
Defined benefit pension credit	1.1	0.6
Selling, General and Administrative Expenses
Defined Benefit Plan Disclosure [Line Items]
Defined benefit pension credit	$ 0.2	$ 0.1

XML

Restructuring Charges (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	$ 2.8	$ 9.0
Gas Cylinders segment
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	2.6	8.9
Elektron segment
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	0.0	0.1
Other
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	$ 0.2	$ 0.0

XML

Revenue - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Revenue, performance obligation satisfied over time, percentage (less than)	1.00%	1.00%
Contract assets	$ 0.5		$ 1.3
Contract asset, reclassified to receivables	0.4
Contract liabilities	$ 0.4		$ 0.5

XML

Shareholders' Equity

3 Months Ended

Mar. 29, 2020

Equity [Abstract]

Shareholders' Equity

Shareholders' Equity

(a) Dividends paid and proposed

In millions	2020		2019
Dividends declared and paid during the year:
Interim dividend paid February 6, 2019 ($0.125 per ordinary share)	$	—	$	3.4
Interim dividend paid February 5, 2020 ($0.125 per ordinary share)	3.4		—
	$	3.4	$	3.4

In millions	2020		2019
Dividends declared and paid after the quarter end (not recognized as a liability at the quarter end):
Interim dividend declared April 1, and paid May 1, 2019: ($0.125 per ordinary share)	$	—	$	3.4
Interim dividend declared April 6, and to be paid May 6, 2020: ($0.125 per ordinary share)	3.4		—
	$	3.4	$	3.4

XML

Basis of Presentation and Responsibility for interim Financial Statements (Policies)

3 Months Ended

Mar. 29, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation

We prepared the accompanying unaudited consolidated condensed financial statements of Luxfer Holdings PLC and all wholly-owned, majority owned or otherwise controlled subsidiaries on the same basis as our annual audited financial statements, except for the adoption for Accounting Standards Update ("ASU") 2016-13, "current expected credit loss model". We condensed or omitted certain information and footnote disclosures normally included in our annual audited financial statements, which we prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP).

Our quarterly financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2019. As used in this report, the terms "we," "us," "our," "Luxfer" and "the Company" mean Luxfer Holdings PLC and its subsidiaries, unless the context indicates another meaning.

In the opinion of management, our financial statements reflect all adjustments, which are of a normal recurring nature, necessary for presentation of financial statements for interim periods in accordance with U.S. GAAP and with the instructions to Form 10-Q in Article 10 of Securities and Exchange Commission (SEC) Regulation S-X.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of our financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and any such differences may be material to our financial statements.

Fiscal year

Our fiscal year ends on December 31. We report our interim quarterly periods on a 13-week quarter basis, ending on a Sunday. The First Quarter, 2020, ended March 29, 2020, and the First Quarter, 2019, ended March 31, 2019.

Adoption of new accounting standards and Accounting standards issued but not yet effective

Adoption of new accounting standards

Current expected credit loss ("CECL") model

On January 1, 2020, the Company adopted ASU 2016-13, financial instruments - Credit Losses (Topic 326): Measurement of credit losses on Financial Instruments prospectively. The ASU replaces the incurred loss impairment model with an expected credit loss impairment model for financial instruments, including trade receivables.

• Under the CECL model, the Company is required to consider whether expected credit losses should be recognized for trade receivables that are considered “current” (i.e., not past due).

• When using historical loss rates in a provision matrix, the Company is required to consider whether and, if so, how the historical loss rates differ from what is currently expected over the life of the trade receivables (on the basis of current conditions and reasonable and supportable forecasts about the future).

Upon adoption, there was no adjustment made to opening retained earnings as at January 1, 2020.

As a result of implementing ASU 2016-13, the Company did not recognize any material additional allowance within Accounts and Other Receivables as at January 1, 2020. Accounts and Other Receivables are shown net of a $1.9 million allowance at March 29, 2020.

The Company is exposed to credit losses primarily through sales of products. The Company’s expected loss allowance methodology for accounts receivable is developed using historical collection experience, current and future economic and market conditions and a review of the current status of customers' trade accounts receivables. Due to the short-term nature of such receivables, the estimate of accounts receivable amounts that may not be collected is based on aging of the accounts receivable balances and the financial condition of customers. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. The Company considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic and determined that the estimate of credit losses was not significantly impacted.

Estimates are used to determine the allowance. It is based on assessment of anticipated receipts and all other historical, current and future information that is reasonably available.

The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected.

In millions	2020
Balance at January 1,	$	1.3
Adoption of ASU 2016-13, cumulative-effect adjustment to retained earnings	—
Provisions for expected credit losses	0.7
Other, including foreign currency translation	(0.1		)
Balance at March 29,	$	1.9

Accounting standards issued but not yet effective

None that will be material to the Company.

XML

Derivatives and Financial Instruments - Schedule of Changes in Level 3 Instruments (Details) $ in Millions	3 Months Ended
	Mar. 29, 2020 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at January 1	$ 0.5
Payments made during year	(0.4)
Release of deferred consideration (recognized in acquisition-related costs)	(0.1)
Balance at December 31	0.0
Total credit for the period included in profit and loss for assets held at the end at March 29	(0.1)
Change in unrealized (gains) or losses for the period included in profit and loss for assets held at the end at March 29,	$ (0.1)

XML

Share Plans - Schedule of Share-based Compensation Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Total share-based compensation charges	$ 0.5	$ 2.6

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Operating activities
Net income / (loss)	$ 6.2	$ (3.8)
Adjustments to reconcile net income / (loss) to net cash used for operating activities
Equity income / (loss) of affiliates	0.0	0.1
Depreciation	3.4	3.4
Amortization of purchased intangible assets	0.2	0.3
Amortization of debt issuance costs	0.1	0.1
Share-based compensation charges	0.5	2.6
Deferred income taxes	0.2	0.8
Asset impairment charges	0.0	(0.2)
Defined benefit pension credit	(1.1)	(0.6)
Defined benefit pension contributions	(1.4)	(1.9)
Changes in assets and liabilities
Accounts and other receivables	(5.6)	(10.4)
Inventories	(2.1)	(3.6)
Other current assets	0.7	0.0
Accounts payable	(7.3)	(0.8)
Accrued liabilities	0.8	(1.7)
Other current liabilities	1.1	7.2
Other non-current assets and liabilities	(0.2)	0.7
Net cash used for operating activities	(4.5)	(7.8)
Investing activities
Capital expenditures	(2.5)	(3.2)
Net cash used for investing activities	(2.5)	(3.2)
Financing activities
Net drawdown of short-term borrowings	0.0	4.2
Net drawdown of long-term borrowings	18.9	11.3
Deferred consideration paid	(0.4)	(0.5)
Proceeds from sale of shares	0.1	1.4
Share-based compensation cash paid	(0.7)	(1.8)
Dividends paid	(3.4)	(3.4)
Net cash from financing activities	14.5	11.2
Effect of exchange rate changes on cash and cash equivalents	(0.4)	0.2
Net increase	7.1	0.4
Cash, cash equivalents and restricted cash; beginning of year	10.3	14.1
Cash, cash equivalents and restricted cash; end of the First Quarter	17.4	14.5
Supplemental cash flow information:
Interest payments	1.3	1.1
Income tax payments	$ 0.1	$ 0.0

XML

Segmental Information - Additional Information (Details)	3 Months Ended
	Mar. 29, 2020 division segment
Segment Reporting [Abstract]
Number of operating segments	2
Number of operating divisions | division	5
Number of reportable segments	2

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) / INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income / (loss)	$ 6.2	$ (3.8)
Other comprehensive (loss) / income
Net change in foreign currency translation adjustment	(7.6)	1.4
Pension and post-retirement actuarial gains , net of $0.1 and $0.1 tax, respectively	0.3	0.5
Cash flow hedges, net of $0.0 and $0.0 of tax, respectively	0.0	0.2
Other comprehensive (loss) / income, net of tax	(7.3)	2.1
Total comprehensive loss	$ (1.1)	$ (1.7)

XML

Restructuring Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 2.8	$ 9.0
Gas Cylinders segment
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 2.6	$ 8.9

XML

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Net sales	$ 103.8	$ 120.4
General industrial
Disaggregation of Revenue [Line Items]
Net sales	39.6	43.7
Transportation
Disaggregation of Revenue [Line Items]
Net sales	30.1	40.0
Defense and emergency
Disaggregation of Revenue [Line Items]
Net sales	29.5	29.2
Healthcare
Disaggregation of Revenue [Line Items]
Net sales	4.6	7.5
Gas Cylinders segment
Disaggregation of Revenue [Line Items]
Net sales	52.6	58.4
Gas Cylinders segment | General industrial
Disaggregation of Revenue [Line Items]
Net sales	11.9	13.1
Gas Cylinders segment | Transportation
Disaggregation of Revenue [Line Items]
Net sales	18.9	20.9
Gas Cylinders segment | Defense and emergency
Disaggregation of Revenue [Line Items]
Net sales	18.1	18.7
Gas Cylinders segment | Healthcare
Disaggregation of Revenue [Line Items]
Net sales	3.7	5.7
Elektron segment
Disaggregation of Revenue [Line Items]
Net sales	51.2	62.0
Elektron segment | General industrial
Disaggregation of Revenue [Line Items]
Net sales	27.7	30.6
Elektron segment | Transportation
Disaggregation of Revenue [Line Items]
Net sales	11.2	19.1
Elektron segment | Defense and emergency
Disaggregation of Revenue [Line Items]
Net sales	11.4	10.5
Elektron segment | Healthcare
Disaggregation of Revenue [Line Items]
Net sales	$ 0.9	$ 1.8

XML

Segmental Information

3 Months Ended

Mar. 29, 2020

Segment Reporting [Abstract]

Segmental Information

Segmental Information

We classify our operations into two core business segments, Gas Cylinders and Elektron, based primarily on shared economic characteristics for the nature of the products and services; the nature of the production processes; the type or class of customer for their products and services; the methods used to distribute their products or provide their services; and the nature of the regulatory environment. The Company has five identified business units, which aggregate into the two reportable segments. Luxfer Gas Cylinders and Luxfer Superform aggregate into the Gas Cylinders segment, and Luxfer MEL Technologies, Luxfer Magtech and Luxfer Graphic Arts aggregate into the Elektron segment. In the first two quarters of 2019, prior to its divestiture, Luxfer Czech Republic also aggregated into the Elektron Segment. A summary of the operations of the segments is provided below:

Gas Cylinders segment

Our Gas Cylinders segment manufactures and markets specialized products using aluminum, titanium and carbon composites, including pressurized cylinders for use in various applications including self-contained breathing apparatus (SCBA) for firefighters, containment of oxygen and other medical gases for healthcare, alternative fuel vehicles, and general industrial. The segment also forms lightweight aluminum and titanium panels into highly complex shapes that are used mainly in the transportation industry.

Elektron segment                                                Our Elektron segment focuses on specialty materials based primarily on magnesium and zirconium, with key product lines including advanced lightweight magnesium alloys with a variety of uses across a variety of industries; magnesium powders for use in countermeasure flares, as well as heater meals; photoengraving plates for graphic arts; and high-performance zirconium-based materials and oxides used as catalysts and in the manufacture of advanced ceramics, fiber-optic fuel cells, and many other performance products.

Other

Other primarily represents unallocated corporate expense and includes non-service related defined benefit pension cost / credit.

Management monitors the operating results of its reportable segments separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated by the chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments as the CEO, using adjusted EBITA⁽¹⁾ and adjusted EBITDA, which we defined as segment income and are based on operating income adjusted for share based compensation charges; loss on disposal of property, plant and equipment, restructuring charges; impairment charges; acquisition and disposal related gains and costs; other charges; depreciation and amortization; and unwind of discount on deferred consideration.

Unallocated assets and liabilities include those which are held on behalf of the Company and cannot be allocated to a segment, such as taxation, investments, cash, retirement benefits obligations, bank and other loans and holding company assets and liabilities.

Financial information by reportable segment for the First Quarter ended March 29, 2020, and March 31, 2019, is included in the following summary:

	Net sales				Adjusted EBITDA
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	52.6	$	58.4	$	3.5	$	4.5
Elektron segment	51.2		62.0		11.6		14.0
Consolidated	$	103.8	$	120.4	$	15.1	$	18.5

	Depreciation and amortization				Restructuring charges
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	1.2	$	1.4	$	2.6	$	8.9
Elektron segment	2.4		2.3		—		0.1
Other	—		—		0.2		—
Consolidated	$	3.6	$	3.7	$	2.8	$	9.0

⁽¹⁾ Adjusted EBITA is adjusted EBITDA less depreciation.

14.    Segmental Information (continued)

	Total assets				Capital expenditures
In millions	2020		2019		2020		2019
Gas Cylinders segment	$	156.6	$	156.0	$	0.5	$	1.1
Elektron segment	201.7		200.8		1.1		2.6
Other	34.2		33.5		—		—
	$	392.5	$	390.3	$	1.6	$	3.7

	Property, plant and equipment, net
In millions	2020		2019
United States	$	56.0	$	57.3
United Kingdom	33.7		36.7
Rest of Europe	1.0		1.0
Asia Pacific	0.3		0.3
Other (2)	3.3		3.6
	$	94.3	$	98.9

The following table presents a reconciliation of Adjusted EBITDA to net income:

In millions	2020			2019
Adjusted EBITDA	$	15.1		$	18.5
Other share-based compensation charges	(0.5		)	(2.6		)
Depreciation and amortization	(3.6		)	(3.7		)
Restructuring charges	(2.8		)	(9.0		)
Impairment charges	—			0.2
Acquisition costs	(0.2		)	(4.6		)
Defined benefits pension pension credit	1.1			0.6
Interest expense, net	(1.2		)	(1.1		)
Provision for income taxes	(1.7		)	(2.1		)
Net income	$	6.2		$	(3.8	)

14.    Segmental Information (continued)

The following tables present certain geographic information by geographic region for the First Quarter ended March 29, 2020, and March 31, 2019:

	Net Sales(1)
	2020				2019
	$M		Percent		$M		Percent
United States	$	59.7	57.5	%	$	61.4	51.0	%
U.K.	7.4		7.1	%	11.5		9.6	%
Germany	3.6		3.5	%	8.2		6.8	%
Italy	4.4		4.2	%	6.5		5.4	%
France	4.6		4.4	%	5.2		4.3	%
Top five countries	$	79.7	76.8	%	$	92.8	77.1	%
Rest of Europe	7.1		6.8	%	11.8		9.8	%
Asia Pacific	11.5		11.1	%	11.6		9.6	%
Other (2)	5.5		5.3	%	4.2		3.5	%
	$	103.8			$	120.4

(1) Net sales are based on the geographic destination of sale.

(2) Other includes Canada, South America, Latin America and Africa.

XML

Basis of Presentation and Responsibility for interim Financial Statements (Tables)

3 Months Ended

Mar. 29, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Allowance for Credit Losses on Financing Receivables

The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected.

In millions	2020
Balance at January 1,	$	1.3
Adoption of ASU 2016-13, cumulative-effect adjustment to retained earnings	—
Provisions for expected credit losses	0.7
Other, including foreign currency translation	(0.1		)
Balance at March 29,	$	1.9

XML

Share Plans (Tables)

3 Months Ended

Mar. 29, 2020

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation Expense

Total share-based compensation expense for the quarters ended March 29, 2020, and March 31, 2019, was as follows:

	First Quarter
In millions	2020		2019
Total share-based compensation charges	$	0.5	$	2.6

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table illustrates the assumptions used in deriving the fair value of share options granted during the First Quarter of 2020 and the year-ended December 31, 2019:

	2020	2019
Dividend yield (%)	2.10	2.10
Expected volatility range (%)	39.00	35.06 - 44.20
Risk-free interest rate (%)	1.60	0.74 - 2.52
Expected life of share options range (years)	4.00	0.50 - 4.00
Weighted average exercise price ($)	$1.00	$1.00
Model used	Black-Scholes	Black-Scholes & Monte-Carlo

XML

Supplementary balance sheet information (Tables)

3 Months Ended

Mar. 29, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Balance Sheet

Supplementary balance sheet information

	March 29,			December 31,
In millions	2020			2019
Accounts and other receivables
Trade receivables	$	62.2		$	52.4
Related parties	2.6			2.7
Prepayments and accrued income	4.9			6.7
Derivative financial instruments	0.4			0.3
Other receivables	3.5			4.2
Total accounts and other receivables	$	73.6		$	66.3
Inventories
Raw materials and supplies	$	34.0		$	33.4
Work-in-process	33.7			32.2
Finished goods	26.2			28.9
Total inventories	$	93.9		$	94.5
Other current assets
Held-for-sale assets	$	3.8		$	3.9
Income tax receivable	0.3			1.1
Total other current assets	$	4.1		$	5.0
Property, plant and equipment, net
Land, buildings and leasehold improvements	$	68.4		$	68.1
Machinery and equipment	278.2			287.7
Construction in progress	7.0			8.9
Total property, plant and equipment	353.6			364.7
Accumulated depreciation and impairment	(259.3		)	(265.8		)
Total property, plant and equipment, net	$	94.3		$	98.9
Other current liabilities
Contingent liabilities	$	7.0		$	6.6
Derivative financial instruments	0.6			—
Operating lease liability	3.1			3.3
Other current liabilities	1.5			2.4
Total other current liabilities	$	12.2		$	12.3
Other non-current liabilities
Contingent liabilities	$	0.9		$	0.9
Operating lease liability	10.6			11.7
Other non-current liabilities	0.2			0.2
Total other non-current liabilities	$	11.7		$	12.8

Schedule of Current Held-for-Sale Assets and Liabilities

Held-for-sale assets and liabilities

Held-for-sale assets	March 29,		December 31,
In millions	2020		2019
Property, plant and equipment	$	3.7	$	3.7
Inventory	0.1		0.2
Held-for-sale assets	$	3.8	$	3.9

XML

Earnings per share

3 Months Ended

Mar. 29, 2020

Earnings Per Share [Abstract]

Earnings per share

Earnings per share

Basic earnings per share are computed by dividing net income for the period by the weighted-average number of ordinary shares outstanding, net of Treasury shares and shares held in ESOP. Diluted earnings per share are computed by dividing net income for the period by the weighted average number of ordinary shares outstanding and the dilutive ordinary shares equivalents.

Basic and diluted earnings per share were calculated as follows:

	First Quarter
In millions except share and per-share data	2020		2019
Basic earnings:
Net income / (loss)	$	6.2	$	(3.8	)
Weighted average number of £0.50 ordinary shares:
For basic earnings per share	27,440,423		27,032,677
Dilutive effect of potential common stock	453,635		—
For diluted earnings per share	27,894,058		27,032,677
Earnings / (loss) per share using weighted average number of ordinary shares outstanding:
Basic earnings / (loss) per ordinary share	$	0.23	$	(0.14	)
Diluted earnings / (loss) per ordinary share	$	0.22	$	(0.14	)

In the first quarter of 2019, basic average shares outstanding and diluted average shares outstanding were the same because the effect of potential shares of common stock was anti-dilutive since the Company generated a

net loss. As a result, 735,730 shares combined were not included in the computation of diluted EPS for the first quarter of 2019.

XML

Goodwill and other identifiable intangible assets

3 Months Ended

Mar. 29, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and other identifiable intangible assets

Goodwill and other identifiable intangible assets

Changes in goodwill during the First Quarter, ended March 29, 2020, were as follows:

In millions	Gas Cylinders			Elektron			Total
At January 1, 2020	$	27.0		$	41.8		$	68.8
Exchange difference	(1.6		)	(1.0		)	(2.6		)
Balance at March 29, 2020	$	25.4		$	40.8		$	66.2

Identifiable intangible assets consisted of the following:

	March 29, 2020							December 31, 2019
In millions	Gross		Accumulated amortization			Net		Gross		Accumulated amortization			Net
Customer relationships	$	13.4	$	(4.8	)	$	8.6	$	13.4	$	(4.6	)	$	8.8
Technology and trading related	7.6		(3.2		)	4.4		8.1		(3.3		)	4.8
	$	21.0	$	(8.0	)	$	13.0	$	21.5	$	(7.9	)	$	13.6

Identifiable intangible asset amortization expense was $0.2 million and $0.3 million for the First Quarter of 2020 and 2019 respectively.

Intangible asset amortization expense during the remainder of 2020 and over the next five years is expected to be approximately $0.5 million in 2020, $0.7 million in 2021, $0.7 million in 2022, $0.7 million in 2023, $0.7 million in 2024 and $0.7 million in 2025.

XML

Income Taxes

3 Months Ended

Mar. 29, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

We manage our affairs so that we are centrally managed and controlled in the United Kingdom (“U.K.”) and therefore have our tax residency in the U.K. The provision for income taxes consists of provisions for the U.K. and international income taxes. We operate in an international environment with operations in various locations outside the U.K. Accordingly, the consolidated income tax rate is a composite rate reflecting the earnings in the various locations and the applicable rates.

The effective income tax rate for the First Quarter ended March 29, 2020, was 21.5%, compared to negative 131.3% for the First Quarter ended March 31, 2019. The 2019 rate was affected by the impact of non-deductible expenses related to the aborted acquisition of Neo Performance Materials and restructuring activities. The tax rate in any quarter can be affected positively or negatively by adjustments that are required to be reported in the specific quarter of resolution.

XML

Segmental Information - Financial information by reportable segment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 103.8	$ 120.4
Adjusted EBITDA	15.1	18.5
Depreciation and amortization	3.6	3.7
Restructuring charges	2.8	9.0
Total assets	392.5	390.3	$ 390.3
Capital expenditures	1.6	3.7
Gas Cylinders segment
Segment Reporting Information [Line Items]
Net sales	52.6	58.4
Adjusted EBITDA	3.5	4.5
Depreciation and amortization	1.2	1.4
Restructuring charges	2.6	8.9
Elektron segment
Segment Reporting Information [Line Items]
Net sales	51.2	62.0
Adjusted EBITDA	11.6	14.0
Depreciation and amortization	2.4	2.3
Restructuring charges	0.0	0.1
Other
Segment Reporting Information [Line Items]
Depreciation and amortization	0.0	0.0
Restructuring charges	0.2	0.0
Operating Segments | Gas Cylinders segment
Segment Reporting Information [Line Items]
Total assets	156.6	156.0
Capital expenditures	0.5	1.1
Operating Segments | Elektron segment
Segment Reporting Information [Line Items]
Total assets	201.7	200.8
Capital expenditures	1.1	2.6
Corporate, Non-Segment
Segment Reporting Information [Line Items]
Total assets	34.2	33.5
Capital expenditures	$ 0.0	$ 0.0

XML

Supplementary balance sheet information - Schedule of Condensed Balance Sheet (Details) - USD ($) $ in Millions	Mar. 29, 2020	Dec. 31, 2019
Accounts and other receivables
Trade receivables	$ 62.2	$ 52.4
Related parties	2.6	2.7
Prepayments and accrued income	4.9	6.7
Derivative financial instruments	0.4	0.3
Other receivables	3.5	4.2
Total accounts and other receivables	73.6	66.3
Inventories
Raw materials and supplies	34.0	33.4
Work-in-process	33.7	32.2
Finished goods	26.2	28.9
Total inventories	93.9	94.5
Other current assets
Held-for-sale assets	3.8	3.9
Income tax receivable	0.3	1.1
Total other current assets	4.1	5.0
Property, Plant and Equipment [Abstract]
Total property, plant and equipment	353.6	364.7
Accumulated depreciation and impairment	(259.3)	(265.8)
Total property, plant and equipment, net	94.3	98.9
Other current liabilities
Contingent liabilities	7.0	6.6
Derivative financial instruments	0.6	0.0
Operating lease liability	3.1	3.3
Other current liabilities	1.5	2.4
Total other current liabilities	12.2	12.3
Other non-current liabilities
Contingent liabilities	0.9	0.9
Operating lease liability	10.6	11.7
Other non-current liabilities	0.2	0.2
Total other non-current liabilities	11.7	12.8
Land, buildings and leasehold improvements
Property, Plant and Equipment [Abstract]
Total property, plant and equipment	68.4	68.1
Machinery and equipment
Property, Plant and Equipment [Abstract]
Total property, plant and equipment	278.2	287.7
Construction in progress
Property, Plant and Equipment [Abstract]
Total property, plant and equipment	$ 7.0	$ 8.9

XML

Debt - Schedule of Maturities of Company's Debt (Details) - USD ($) $ in Millions	Mar. 29, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
2020	$ 0.0
2021	25.0
2022	34.7
2023	25.0
2024	0.0
2025	0.0
Thereafter	25.0
Total	109.7
Loan Notes | Loan Notes due 2021
Debt Instrument [Line Items]
2020	0.0
2021	25.0
2022	0.0
2023	0.0
2024	0.0
2025	0.0
Thereafter	0.0
Total	25.0	$ 25.0
Loan Notes | Loan Notes due 2023
Debt Instrument [Line Items]
2020	0.0
2021	0.0
2022	0.0
2023	25.0
2024	0.0
2025	0.0
Thereafter	0.0
Total	25.0	25.0
Loan Notes | Loan Notes due 2026
Debt Instrument [Line Items]
2020	0.0
2021	0.0
2022	0.0
2023	0.0
2024	0.0
2025	0.0
Thereafter	25.0
Total	25.0	25.0
Revolving credit facility
Debt Instrument [Line Items]
2020	0.0
2021	0.0
2022	34.7
2023	0.0
2024	0.0
2025	0.0
Thereafter	0.0
Total	$ 34.7	$ 17.5